Back To Index  <<  Back To Terminology

final Value Set eHDSISubstance 2025‑02‑18 12:29:00

This terminology is a snapshot as of 2026‑02‑11 10:48:51. Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.
Id 1.3.6.1.4.1.12559.11.10.1.3.1.42.61 Effective Date 2025‑02‑18 12:29:00
Other versions this id:
Status final Final Version Label 202502
Name eHDSISubstance Display Name eHDSISubstance
Description The Value Set is used to code the substances of medicine.
Source Code System
2.16.840.1.113883.3.6905.2 - FHIR: urn:oid:2.16.840.1.113883.3.6905.2
Level/ Type Code Display Name Code System
0‑L
300000050539
DTx-1252
2.16.840.1.113883.3.6905.2
0‑L
300000040718
SPL23-2
2.16.840.1.113883.3.6905.2
0‑L
300000037069
SPL84-23-1
2.16.840.1.113883.3.6905.2
0‑L
300000054911
Pasifolate exatecan ELU001
2.16.840.1.113883.3.6905.2
0‑L
300000044609
Cepadacursen sodium CIVI 007 sodium
2.16.840.1.113883.3.6905.2
0‑L
300000044624
all-P-ambo-5'-O-(26-[(2-acetamido-2-deoxy-beta-D-galactopyranosyl)oxy]-11,14- bis({4-[2-(2-{2-[(2-acetamido-2-deoxy-beta-D-galactopyranosyl)oxy]ethoxy}ethoxy)ethoxy]acetamido}butyl)-1,10,13,16- tetraoxo-1-sulfanyl-2,18,21,24,26-pentaoxa-9,12,15-triaza-1λ5- phosphahexacosan-1-yl)-2'-O,4'C-methylene-P-thioadenylyl-(3'->5')-2'-O,4'Cmethylene-P-thioadenylyl-(3'->5')-2'-O,4'C-methylene-5-methyl-P-thiouridylyl- (3'->5')-2'-deoxy-P-thioguanylyl-(3'->5')-2'-deoxy-P-thiocytidylyl-(3'->5')-Pthiothymidylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thiocytidylyl- (3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'- deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-O,4'Cmethylene-P-thiocytidylyl-(3'->5')-2'-O,4'C-methylene-5-methyl-P-thiocytidylyl- (3'->5')-2'-O,4'C-methylene-5-methyl-P-thiocytidylyl-(3'->5')-2'-O,4'Cmethylene-P-thioadenosine
2.16.840.1.113883.3.6905.2
0‑L
300000052084
RNA, ([1'-de(6-Amino-9H-purin-9-yl)]dA-(5'->5')-sp-Am-Cm-Gm-Gm-Gm-Am-Cm-Am-(2'-deoxy-2'-fluoro)G-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)A-Um-Um-Cm-Um-CmAm-Gm-Um-Im-Am-(3'->3')-sp-[1'-de(6-amino-9H-purin-9-yl)]dA), 3'-[O-[cis-4-[(3S,8S)-17-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-3,8-bis[[[2-[2-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]ethoxy]ethyl]amino]carbonyl]-1,6,11-trioxo-15-oxa-2,7,12-triazaheptadec-1-yl]cyclohexyl] hydrogen phosphorothioate] sodium salt, complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)C-spAm-sp-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)G-Am-Gm-Am-Am-Um-(2'-deoxy2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)C-Cm-(2'-deoxy-2'-fluoro)G-sp-Um) sodium salt (1:23:1:20)
2.16.840.1.113883.3.6905.2
0‑L
300000033141
(2R)-5-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(1S)-2-[2-[[[(2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-4-methyl-3-[3-methylbutanoyloxymethyl-[(2S,3S)-3-methyl-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]pentanoyl]amino]pentyl]-1,3-thiazole-4-carbonyl]amino]-5-(4-hydroxyphenyl)-2-methylpentanoyl]amino]carbamoyloxy]ethyldisulfanyl]-1-carboxyethyl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxopentanoic acid
2.16.840.1.113883.3.6905.2
0‑L
300000046108
2'-O, 4'-C-Methylene-P-thio-adenylyl-(3'->5')-2'-O, 4'-C-methylene-P-thioguanylyl-(3'->5')-2'-O, 4'-C-methylene-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-Pthio-adenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-O, 4'-Cmethylene-5-methyl-P-thio-cytidylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-Pthio-uridylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-uridylyl-(3'->5')-2'-O, 4'-C-methyleneguanosine heptadecasodium salt
2.16.840.1.113883.3.6905.2
0‑L
300000046107
2'-O, 4'-C-Methylene-P-thio-adenylyl-(3'->5')-2'-O, 4'-C-methylene-P-thioguanylyl-(3'->5')-2'-O, 4'-C-methylene-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-cytidylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-uridylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-uridylyl-(3'->5')-2'-O, 4'-C-methyleneguanosine
2.16.840.1.113883.3.6905.2
0‑L
300000057685
RNA, (Am-sp-(2′-deoxy-2′-fluoro)C-sp-Am-Um-Am-(2′-deoxy-2′-fluoro)A-Gm-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)C-Am-Um-Um-Am-(2′-deoxy-2′-fluoro)U-Cm-(2′-deoxy-2′-fluoro)C-Um-Am-Am-Um-Gm-sp-Gm-sp-Gm), complex with RNA (Cm-sp-Am-sp-Um-Um-Am-Gm-(2′-deoxy-2′-fluoro)G-Am-(2′-deoxy-2′-fluoro)U-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)A-Um-Gm-Um-Cm-Um-Um-Am-Um-Gm-Um) 3′-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate] (1:1)
2.16.840.1.113883.3.6905.2
0‑L
300000013627
(2S,3S,4S,5R,6R)-3-[(2R,3R,4S,5R,6R)-5-[2-[2-[2-[2-[[(2S)-6-[5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[4-[[(3S)-4-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-4-oxobutanoyl]amino]butanoylamino]hexanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-3,4-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-6-[(2R,3R,4S,5R,6S)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxane-2-carboxylic acid, octasodium salt
2.16.840.1.113883.3.6905.2
0‑L
300000039066
All-P-ambo-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioadenylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioguanylyl-(3'->5')-P-thiothymidylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioguanylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioguanylyl-(3'->5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'->5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'->5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-5-methyl-P-thiocytidylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]guanosine sodium (1:15)
2.16.840.1.113883.3.6905.2
0‑L
300000042350
(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-6-aminohexanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid
2.16.840.1.113883.3.6905.2
0‑L
100000175540
(2S,3S,4S,5R,6R)-3-[(2R,3R,4S,5R,6R)-5-[2-[2-[2-[2-[[(2S)-6-[5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[4-[[(3S)-4-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-4-oxobutanoyl]amino]butanoylamino]hexanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-3,4-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-6-[(2R,3R,4S,5R,6S)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxane-2-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000043979
(2S,3S,4S,5R,6R)-3-((2R,3R,4S,5R,6R)-5-(2-(2-(2-(2-(4-(((3s)-4-(((1R)-1-((4-carbamimidoylphenyl)methyl)-2-oxo-2-(1-piperidyl)ethyl)amino)-3-((4-methoxy-2,3,6-trimethyl-phenyl)sulfonylamino)-4-oxo-butanoyl)amino)butanoylamino)ethoxy)ethoxy)ethoxy)ethoxy)-3,4-dimethoxy-6-(sulfooxymethyl)tetrahydropyran-2-yl)oxy-6-((2r,3r,4s,5r,6r)-6-((2r,3s,4s,5r,6r)-2-carboxy-6-((2r,3r,4s,5r,6s)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)tetrahydropyran-3-yl)oxy-4,5-dimethoxy-tetrahydropyran-3-yl)oxy-4,5-disulfooxy-2-(sulfooxymethyl)tetrahydropyran-3-yl)oxy-4,5-dimethoxy-tetrahydropyran-2-carboxylic acid sodium hydride
2.16.840.1.113883.3.6905.2
0‑L
300000051686
RNA, (Gm-sp-Um-sp-Gm-Cm-(2"-deoxy-2"-fluoro)A-(2"-deoxy-2"-fluoro)C-(2"-deoxy-2"-fluoro)U-Um-Cm-Gm-Cm-Um-Um-Cm-Am-Cm-Am), 3"-[[[rel-(3S,4R)]-1-(9-carboxy-1-oxononyl)-4-(hydroxymethyl)-3,4-dimethyl-3-pyrrolidinyl]methyl hydrogen phosphate], carboxamide with L-glutamoylbis[N-[3,5-bis[[[2-[2-[2-[[2-(acetylamino)-2-deoxy-β-Dgalactopyranosyl]oxy]ethoxy]ethoxy]ethyl]amino]carbonyl]phenyl]glycinamide], sodium salt, complex with RNA (Um-sp-(2"-deoxy-2"-fluoro)G-sp-Um-Gm-Am-Am-GmCm-Gm-Am-Am-Gm-Um-(2"-deoxy-2"-fluoro)G-Cm-(2"-deoxy-2"-fluoro)A-Cm-Am-Cmsp-Gm-sp-Gm-U) sodium salt (1:17:1:21)
2.16.840.1.113883.3.6905.2
0‑L
300000042351
2-[4-[2-[[1-[2-[[(2R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(3S,4S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]piperidin-4-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate gallium-68(3+)
2.16.840.1.113883.3.6905.2
0‑L
100000175547
ESSENTIAL OIL FROM MELISSA OFFICINALIS LEAF (UP TO 536 MG), INULA HELENIUM ROOT (UP TO 714 MG), ANGELICA ARCHANGELICA ROOT (UP TO 714 MG), ZINGIBER OFFICINALE ROOT (UP TO 714 MG), SYZYGIUM AROMATICUM FLOWER (UP TO 285 MG), ALPINIA OFFICINARUM ROOT (UP TO 285 MG), PIPER NIGRUM FRUIT (UP TO 71 MG), GENTIANA LUTEA ROOT (UP TO 714 MG), MYRISTICA FRAGRANS SEED (UP TO 71 MG), CITRUS AURANTIUM PEEL (UP TO 714 MG), CINNAMOMUM VERUM BARK (UP TO 321 MG), CINNAMOMUM CASSIA FLOWER (UP TO 36 MG) AND ELETTARIA CARDAMOMUM SEED (UP TO 10 MG)
2.16.840.1.113883.3.6905.2
0‑L
100000175548
DISTILLATE FROM A MIXTURE (UP TO): MELISSA OFFICINALIS LEAF (536 MG), INULA HELENIUM ROOT (714 MG), ANGELICA ARCHANGELICA ROOT (714 MG), ZINGIBER OFFICINALE ROOT (714 MG), SYZYGIUM AROMATICUM FLOWER (285 MG), ALPINIA OFFICINARUM ROOT (285 MG), PIPER NIGRUM FRUIT (71 MG), GENTIANA LUTEA ROOT (714 MG), MYRISTICA FRAGRANS SEED (71 MG), CITRUS AURANTIUM PEEL (714 MG), CINNAMOMUM CASSIA BARK (321 MG), CINNAMOMUM VERUM FLOWER (36 MG) AND ELETTARIA CARDAMOMUM SEED (10 MG). EXTRACTION SOLVENTS: ETHANOL 96% (V/V) AND WATER, PURIFIED
2.16.840.1.113883.3.6905.2
0‑L
300000026351
3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, homopolymer,9-arm star compd. with 1,1'-[2-[11,11-bis[15-bromo-11,11-bis[(2-bromo-2-methyl-1-oxopropoxy)methyl]-15-methyl-3,7,14-trioxo-9,13-dioxa-2,6-diazahexadec-1-yl]-44-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-4,8,26,42-tetraoxo-2,13,16,19,22,29,32,35,38-nonaoxa-5,9,25,41-tetraazatetratetracont-1-yl]-2-[(2-bromo-2-methyl-1-oxopropoxy)methyl]-1,3-propanediyl] bis(2-bromo-2-methylpropanoate)
2.16.840.1.113883.3.6905.2
0‑L
300000042370
(2R)-3-[[(2R)-1-[[5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(3S,4S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxopentyl]amino]-1-oxo-3-sulfopropan-2-yl]amino]-2-[(3-cyano-4-(18F)fluoranylbenzoyl)amino]-3-oxopropane-1-sulfonic acid
2.16.840.1.113883.3.6905.2
0‑L
100000183786
100 ML CONSISTS OF: DISTILLATE FROM A MACERATE OF MELISSA OFFICINALIS LEAF 429-536 MG,HELENII RHIZOMA 226-714 MG, ANGELICA ROOT 209-714 MG, ZINGIBER OFFICINALE RHIZOME 235-714 MG, SYZYGIUM AROMATICUM FLOS 190-285 MG, GALANGAL RHIZOME 70-285 MG, PIPER NIGRUM FRUIT 16-71 MG, GENTIANA ROOT 571-714 MG, NUTMEG SEEDS 36-71 MG, BITTER-ORANGE EPICARP AND MESOCARP 99-714 MG, CINNAMOMI CORTEX 223-321 MG, CINNAMON BLOSSOM 15-36 MG, CARDAMOMI FRUCTUS 6-10 MG: EXTRACTION SOLVENT: ETHANOL 79% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000052116
(4S)-4-[(2-Aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
2.16.840.1.113883.3.6905.2
0‑L
100000174602
TINCTURE FROM BLACK POPLAR BUD, CAPSICUM, CLOVE, OAK BARK, CALENDULA, FLOWER, BAY LAUREL LEAF, PEPPERMINT LEAF, DILL FRUIT, HAWTHORN BERRIES, WORMWOOD, ALLSPICE, LOVAGE ROOT, VALERIAN ROOT, HOP STROBILE, BITTER-ORANGE EPICARP AND MESOCARP, FRANGULA BARK, WILLOW BARK, CARAWAY FRUIT, BIRCH LEAF, MEADOWSWEET, ST. JOHN'S WORT, HYSSOP, YARROW, THYME, TORMENTIL, ROWAN FRUIT, DOG ROSE (10,5/0,3/5/2/2/5/2/2/2/2/2/2/2/2/3/6/6/6/6/6/6/6/6/6/6/12/12), EXTRACTION SOLVENT: ETHANOL 40% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000013162
Poly[2-[(4-{[1-carboxy-2-(hexadecylcarbamoyl)ethyl]sulfanyl}-2,3-bis({2-[((2S)-2-(2-{[(2R)-2-carbamoyl-(2-{[(2S)-1-ethoxy-3-(3-hydroxy-4oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}ethyl]sulfanyl}-3-{[(2S)-1-ethoxy-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}propanamido)-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)propanoyl ethyl ester))-methoxy]acetyl}oxy)butyl)sulfanyl]-3-(hexadecylcarbamoyl)propanoic acid]-poly(ethylene glycol)-ester]
2.16.840.1.113883.3.6905.2
0‑L
300000039033
(3RS)-1-[(6S,9S)-1-amino-6-[(4-{[({(2S)-2-hydroxy-3-[(12S,13S,14R,15R,32R,34R,36S,62S,65S,92S,93aR,94aR,95S,95aS,97R,99aS,910aR,910bS)-14-methoxy-34-methyl-33,63-bis(methylidene)-11-oxo-9-decahydro-93H-9(2,7)-(2,5-epoxyfuro[2',3':4,5]furo[3,2-b]pyrano[2,3-e]pyrana)-3(2,6)-oxana- 1(2,3),6(2,5)-bis(oxolana)cyclododecaphan-15yl]propyl}carbamoyl)oxy]methyl}phenyl)carbamoyl]-1,8,11-trioxo-9-(propan-2-yl)-14,17-dioxa-2,7,10-triazanonadecan-19-yl]-2,5-dioxopyrrolidin-3-yl
2.16.840.1.113883.3.6905.2
0‑L
300000044789
L-methionylglycyl-L-seryl-L-serylhexa-L-histidyl-L-seryl-L-serylglycyl-L-leucyl-L-valyl-L-prolyl-larginylglycyl-L-seryl-L-histidyl-L-methionyl-L-alanyl-L-seryl-L-methionyl-L-threonylglycylglycyll-glutaminyl-L-glutaminyl-L-methionylglycyl-L-arginyl-L-aspartyl-L-prolyl-des-(1-25)-cysteineproteinase EP-B 2 precursor (Hordeum vulgare) fusion protein with l-asparaginyl-tri-lseryl-L-valyl-L-aspartyl-L-lysyl-L-leucyl-tri-L-alanyl-L-leucyl-L-glutamylhexa-L-histidine
2.16.840.1.113883.3.6905.2
0‑L
300000015302
RNA, [P-deoxy-P-(dimethylamino)] (2',3'-dideoxy-2',3'-imino-2',3'-seco) (2'a->5') (C-m5U-m5U-A-C-A-G-G-C-m5U-C-C-A-A-m5U-A-G-m5U-G-G-m5U-C-A-G-m5U), 5' [P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N-dimethylaminophosphonamidate], 3' [2'a-[N2-acetyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-beta-alanyl-L-arginyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-beta-alanyl-L-arginyl-6-aminohexanoyl-beta-alanyl], octahydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000028882
N-[6-(1-{2-[3,6-bis(2,3-dihydro-1H-indol-1-yl)xanthylium-9-yl]benzene-1-sulfonyl}piperidine-4-carboxamido)hexanoyl]glycylglycyl-L-arginyl-N6-(6-{2-[(1E,3E,5Z)-5-(1-ethyl-3,3-dimethyl-5-sulfonato-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dien-1-yl]-3,3-dimethyl-5-sulfonato-3H-indol-1-ium-1-yl}hexanoyl)-Llysyl-[2-(2-aminoethoxy)ethoxy]acetyl-S-[(3RS)-1-{6-[α-methylpoly(oxyethylene)-ω-amino]-6-oxohexyl}-2,5-dioxopyrrolidin-3-yl]-L-cysteinamide acetate
2.16.840.1.113883.3.6905.2
0‑L
100000137876
DISTILLATE OF MELISSA LEAF (536 MG/100 ML), HELENII RHIZOMA (714 MG/100 ML), ANGELICA ROOT (714 MG/100 ML), ZINGIBER OFFICINALE (GINGER) ROOT (714 MG/100 ML), CLOVES (285 MG/100 ML), GALANGAL RHIZOME (285 MG/100 ML), BLACK PEPPER FRUITS (71 MG/100 ML), GENTIAN ROOT (714 MG/100 ML), NUTMEG SEEDS (71 MG/100 ML), BITTER ORANGE PEEL (714 MG/100 ML), CINNAMOMI CORTEX (321 MG/100 ML), CINNAMON BLOSSOM (36 MG/100 ML), CARDAMOM SEEDS (10 MG/100 ML)
2.16.840.1.113883.3.6905.2
0‑L
300000051639
L-threonyl-L-lysyl-L-phenylalanyl-Lthreonyl-L-leucyl-L-seryl-L-leucyl-L-aspartyl-L-valyl-L-prolyl-l-threonyl-L-asparaginylL-isoleucyl-L-methionyl-L-asparaginyl-L-leucyl-L-leucyl-L-phenylalanyl-L-asparaginylL-isoleucyl-L-alanyl-L-lysyl-L-alanyl-L-lysyl-L-asparaginyl-L-leucyl-L-arginyl-Lalanyl-L-glutaminyl-L-alanyl-L-alanyl-L-alanyl-L-asparaginyl-L-alanyl-L-histidyl-Lleucyl-L-methionyl-L-alanyl-L-glutaminyl-L-isoleucine amide acetate
2.16.840.1.113883.3.6905.2
0‑L
300000044774
(3RS)-1-(6-{[(2S)-1-({(2S)-5-(carbamoylamino)-1-[4-({[(1-{[(2S)-1-{[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl](methyl)amino}-3-methyl-1-oxobutan-2-yl]amino}-2-methyl-1-oxopropan-2-yl)carbamoyl]oxy}methyl)anilino]-1-oxopentan-2-yl}amino)-3-methyl-1-oxobutan-2-yl]amino}-6-oxohexyl)-2,5-dioxopyrrolidin-3-yl
2.16.840.1.113883.3.6905.2
0‑L
300000041538
4-[4-carboxybutyl-[2-[(18S,25S,35S)-35-[(S)-hydroxy(phenyl)methyl]-28-(methoxymethyl)-21-methyl-18-[2-(methylamino)-2-oxoethyl]-16,23,30,33-tetraoxo-25-propan-2-yl-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decazaheptacyclo[34.2.1.12,5.112,15.119,22.126,29.06,11]tritetraconta-1(38),2(43),4,6(11),7,9,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl]carbamoyl]oxycyclohexane-1-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000044630
(3RS)-1-(6-{[(1S)-1-{[(1S)-4-(carbamoylamino)-1-({4-[({[(1S)-1-{[(1S)-1-({(1S,2R)-4-{(2S)-2-[(1R,2R)-3-{[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl}methylcarbamoyl)-2-methylpropyl]carbamoyl}-2-methylpropyl]methylcarbamoyl}oxy)methyl]phenyl}carbamoyl)butyl]carbamoyl}-2-methylpropyl]amino}-6-oxohexyl)-2,5-dioxopyrrolidin-3-yl
2.16.840.1.113883.3.6905.2
0‑L
100000175549
ESSENTIAL OIL DISTILLED IN A 4.04 G ALCOHOL MIXTURE: MELISSA OFFICINALIS LEAF 10.48%, INULA HELENIUM ROOT 13.96%, ANGELICA ARCHANGELICA ROOT 13.96%, ZINGIBER OFFICINALE ROOT 13.96%, SYZYGIUM AROMATICUM FLOWER 5.57%, ALPINIA OFFICINARUM ROOT 5.57%, PIPER NIGRUM FRUIT 1.39%, GENTIANA LUTEA ROOT 13.96%, CITRUS AURANTIUM PEEL 13.96%, CINNAMOMUM CASSIA 6.28%,CINNAMOMUM VERUM FLOWER 0.7% AND ELETTARIA CARDAMOMUM SEEDS 0.2%
2.16.840.1.113883.3.6905.2
0‑L
100000138035
DISTILLATE OF MELISSA LEAF (536 MG/100 ML), HELENII RHIZOMA (714 MG/100 ML), ANGELICA ROOT (714 MG/100 ML), ZINGIBER OFFICINALE (GINGER) ROOT (714 MG/100 ML), CLOVES (285 MG/100 ML), GALANGAL RHIZOME (285 MG/100 ML), BLACK PEPPER FRUITS (71 MG/100 ML), GENTIAN ROOT (714 MG/100 ML), BITTER ORANGE PEEL (714 MG/100 ML), CINNAMOMI CORTEX (321 MG/100 ML), CINNAMON BLOSSOM (36 MG/100 ML), CARDAMOM SEEDS (10 MG/100 ML)
2.16.840.1.113883.3.6905.2
0‑L
300000056945
N-Acetyl-L-alanyl-L-seryl-L-histidyl-L-leucyl-L-seryl-L-threonyl-L-alanyl-L-valyl-L-leucylglycyl-N6-[(22S)-22,42-dicarboxy-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazadotetracontan-1-oyl]-L-lysyl-L-leucyl-L-seryl-2-methylalanyl-L-glutamyl-L-leucyl-L-histidyl-L-lysyl-L-leucyl-L-glutamyl-L-aspartyl-L-tyrosinyl-L-prolyl-L-arginyl-L-threonyl-L-aspartyl-L-valylglycyl-L-alanyl-L-glutamyl-L-seryl-L-prolinamide
2.16.840.1.113883.3.6905.2
0‑L
100000183261
(E)-2-((2s,4s)-4-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-10-(carboxymethyl)-1-hydroxy-13-(2-(2-(2-((e)-3-(3-((3-hydroxy-3,3 diphosphonopropyl)(methyl)amino)propoxy)benzylidene)hydrazine-1-carbonothioyl)hydrazineyl)-2-oxoethyl)-8-oxo-5-thioxo-3,4,6,7,10,13-hexaazapentadec-2-en-15-oic acid
2.16.840.1.113883.3.6905.2
0‑L
300000044783
N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1Hpyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]- 11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin10(5H)-yl]carbonyl]oxy]methyl]phenyl]-L-alaninamide
2.16.840.1.113883.3.6905.2
0‑L
300000044100
[Oxybis(1,1,1,5,5,5-hexamethyltrisiloxane-3,3-diyl)]bis(propane-3,1-diyl) bis(2-methylacrylate), polymer with N,N-dimethylacrylamide, 1-vinylpyrrolidin-2-one, hexane1,6-diyl diacrylate, 2-hydroxyethyl methacrylate, methyl methacrylate, 1,1,1,3,3,3- hexafluoropropan-2-yl methacrylate, 3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl methacrylate and allyl methacrylate
2.16.840.1.113883.3.6905.2
0‑L
300000052292
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate gallium-68(3+)
2.16.840.1.113883.3.6905.2
0‑L
300000042310
Cyclohexanecarboxylic acid, 4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1- yl)methyl]-, 2-[2-[[O-6-deoxy-alfa-L-galactopyranosyl-(1->2)-O- beta-D-galactopyranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->3)-O-alfa-D-galactopyranosyl-(1->4)-O- beta-D-galactopyranosyl-(1->4)-beta-D- glucopyranosyl]oxy]ethyl]hydrazide, reaction products with hemocyanin keyhole limpet
2.16.840.1.113883.3.6905.2
0‑L
300000051875
5-{[(2S)-1-{[(2S)-1-{4-[(5S,8S,11S,12R)-11-[(2S)-Butan-2-yl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-2-oxoethyl)-4,10-dimethyl-3,6,9-trioxo-5,8-di(propan-2-yl)-2,13-dioxa-4,7,10-triazatetradecan-1-yl]anilino}-5-(carbamoylamino)-1-oxopentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]amino}-5-oxopentanoyl
2.16.840.1.113883.3.6905.2
0‑L
300000008875
L-cysteinyl-L-tryptophyl-L-leucyl-L-cysteinyl-L-arginyl-L-alanyl- L-leucyl-L-isoleucyl-L-lysyl-L-arginyl-L-isoleucyl-L-glutaminyl-L-alanyl-L- leucyl-L-isoleucyl-L-prolyl-L-lysylglycylglycyl-L-arginyl-L-leucyl-L- leucyl-L-prolyl-L-glutaminyl-L-leucyl-L-valyl-L-cysteinyl-L-arginyl-L- leucyl-L-valyl-L-leucyl-L-arginyl-L-cysteinyl-L-serine, cyclic (1->33),(4->27)-bis(disulfide)
2.16.840.1.113883.3.6905.2
0‑L
300000033220
(2R)-3-(((2-(6-((3-(((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2Hpyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-(hydroxymethyl)tetrahydro -2Hpyran-2-yl)oxy)propyl)amino)-6-oxohexanamido)ethoxy)(hydroxy)phosphoryl)oxy) propane-1,2-diyl dioleate, sodium salt
2.16.840.1.113883.3.6905.2
0‑L
300000041342
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
2.16.840.1.113883.3.6905.2
0‑L
300000051873
5-(6-{[(1-{(34S)-38-Amino-34-[(4-{[({[(4S)-4-ethyl-11-{2-[N-(propan-2-yl)methanesulfonamido]ethyl}-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl]oxy}carbonyl)oxy]methyl}phenyl)carbamoyl]-28,32-dioxo-3,6,9,12,15,18,21,24,30-nonaoxa-27,33-diazaoctatriacontan-1-yl}-1H-1,2,3-triazol-4-yl)methyl]amino}-6-oxohex-1-yn-1-yl)pyrimidin-2-yl
2.16.840.1.113883.3.6905.2
0‑L
300000056685
2'-O-4'-C-(S)-Ethyl-P-thioadenylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thioguanylyl-(3'-O->5'-O)-2'-O-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thioadenylyl-(3'-O->5'-O)-2'-fluoro-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thiouridylyl-(3'-O->5'-O)-2'-O-methyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-adenosine
2.16.840.1.113883.3.6905.2
0‑L
300000057543
(2S)-2-Cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(6S,8S,14S)-21-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]acetamide
2.16.840.1.113883.3.6905.2
0‑L
300000050554
2R,4R,5S,6S)-5-Acetamido-2-[[(2R,3S,4S,5R,6S)-5-[(2R,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxymethyl]-4-hydroxy-6-[(1S,2S)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000033238
(2R)-3-(((2-(6-((3-(((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2Hpyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-(hydroxymethyl)tetrahydro -2Hpyran-2-yl)oxy)propyl)amino)-6-oxohexanamido)ethoxy)(hydroxy)phosphoryl)oxy) propane-1,2-diyl dioleate
2.16.840.1.113883.3.6905.2
0‑L
300000045067
(2S)-5-(carbamoylamino)-N-[4-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]sulfamoyl]phenyl]-2-[[(2S)-2-[3-[2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanamide
2.16.840.1.113883.3.6905.2
0‑L
100000166260
LIQUID EXTRACT (1 : 10.6-13.0) OF ARTICHOKE LEAF, GENTIAN ROOT, TURMERIC ROOT, DANDELION HERB WITH ROOT, GINGER, YARROW HERB, BITTER FENNEL, MATRICARIA FLOWER, BITTER-ORANGE EPICARP AND MESOCARP, BLESSED THISTLE, BOGBEAN LEAF, CARDAMOM, WORMWOOD (41.5 : 11.8 : 8.5 : 7.2 : 5.9 : 5.8 : 5.8 : 4.3 : 4.3 : 2.1 : 1.0 : 1.0 : 0.57), EXTRACTION AGENT: WATER
2.16.840.1.113883.3.6905.2
0‑L
300000046505
(S)-1-(acetyl-L-prolyl-L-prolyl)-N-((S)-1-((S)-2-(((S)-1-(((S)-1-(((S)-1-(((2S,3S)-1-(((S)-1,6-diamino-1-oxohexan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)carbamoyl)pyrrolidin-1-yl)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)pyrrolidine-2-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000057717
N-[N6-[N-(17-Carboxy-1-oxoheptadecyl)-L-gamma-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-L-gamma-glutamyl]-D-lysyl-N-methylglycyl]-32a-[N6-[N-(17-carboxy-1-oxoheptadecyl)-L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-L-γ-glutamyl]-L-lysine]-1-32-human parathyroid hormone
2.16.840.1.113883.3.6905.2
0‑L
300000001485
N1-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-N6-((S)-1-(((S)-1-((3-((((S)-8-methoxy-6-oxo-11,12,12a,13-tetrahydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)-5-((((S)-8-methoxy-6-oxo-12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)adipamide
2.16.840.1.113883.3.6905.2
0‑L
300000051687
4-{2-[(E)-(2-{4-[(2S,5S,20S,24S)-5-Benzyl-2,20,24,26-tetracarboxy-4,7,17,22-tetraoxo-10,13-dioxa-3,6,16,21,23-pentaazahexacosyl]phenoxy}-3-{(E)-2-[(2E)-3,3- dimethyl-5-sulfo-1-(4-sulfobutyl)-1,3-dihydro-2H-indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl)ethenyl]-3,3-dimethyl-5-sulfo-3H-indol-1-ium-1-yl}butane-1-sulfonate heptasodium
2.16.840.1.113883.3.6905.2
0‑L
300000031093
Sodium 1-(1-carboxy-4,21-dioxo-1-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-8,11,14,17-tetraoxa-5,20-diazahexacosan-26-yl)-2-((E)-2-((E)-3-(2-((E)-3,3-dimethyl-5-sulfonato-1-(4-sulfonatobutyl)indolin-2-ylidene)ethylidene)-2-(4-sulfonatophenoxy)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-3H-indol-1-ium-5-sulfonate
2.16.840.1.113883.3.6905.2
0‑L
300000005660
S-[5-(omega-methoxypoly(oxyethylene)-2-oxopentyl)]-L-cysteinylglycyl-L-serinylglycylgylcyl-L-isoleucyl-L-lysyl-L-glutamyl-L-phenylalanyl-L-leucyl-L-glutaminyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-histyl-L-isoleucyl-L-valyl-L-glutaminyl-L-serinyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-threonyl-L-serinamide, acetate salt
2.16.840.1.113883.3.6905.2
0‑L
300000040910
(2S,3R)-2-[[(3S)-4-amino-3-(3-chlorophenyl)butanoyl]amino]-N-[(2S)-3-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]propan-2-yl]-3-hydroxybutanamide acetic acid salt
2.16.840.1.113883.3.6905.2
0‑L
300000014560
Adalimumab conjugated with (4S)-4-[2-(2-bromoacetamido)acetamido]-5-{3-[(4-{(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-4a,6a-dimethyl-2-oxo-6b-[(phosphonooxy)acetyl]-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8-yl}phenyl)methyl] anilino}-5-oxopentanoic acid
2.16.840.1.113883.3.6905.2
0‑L
100000142686
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY FOUR-TIME POTENTIATION WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS AND SUBSEQUENT POTENTIATION WITH SUGAR SYRUP PRODUCED THERE FROM)(HAB, SV5B)
2.16.840.1.113883.3.6905.2
0‑L
100000139492
EXTRACTUM COMPOSITUM (1:1,3-1,6) EX: AGROPYRI RHIZOMATE 12,5 P.,ALLII CEPAE SQUAMA 5,0 P.,BETULAE FOLIO 10,0 P.,FOENUGRAECI SEMINE 15,0 P.,PETROSELINI RADICE 17,5 P.,SOLIDAGINIS HERBA 5,0 P.,EQUISETI HERBA 10,0 P.,LEVISTICI RADICE 10,0 P.,POLYGONI AVICULARIS HERBA 15,0 P. – 67,2 GEKSTRAHENT – ETANOL 45% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000046886
Benzoic acid, 2-hydroxy-, monosodium salt, mixture with 2-(diethylamino)ethyl-4-aminobenzoate monohydrochloride, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, 5,5-di-2-propenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate
2.16.840.1.113883.3.6905.2
0‑L
300000050816
1-((1R,2S)-1-((((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4)benz(1,2-b)oxet-9-yl)oxy)carbonyl)-2-(((1,1-dimethylethoxy)carbonyl)amino)-2-phenylethyl) butanedioate
2.16.840.1.113883.3.6905.2
0‑L
300000037118
Grass pollen allergen extract from Agrostis capillaris/tenuis, Bromus spp., Dactylis glomerata, Cynosurus cristatus, Secale cereale, Arrhenatherum elatius, Festuca pratensis, Alopecurus pratensis, Poa pratensis/trivialis, Lolium perenne/multiflorum, Anthoxanthum odoratum, Phleum pratense and Holcus lanatus
2.16.840.1.113883.3.6905.2
0‑L
300000008876
L-isoleucyl-L-prolyl-L-seryl-L-seryl-L-prolyl-L-valyl-L- histidyl-L-leucyl-L-lysyl-L-arginyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L- leucyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-isoleucyl-L-leucyl-L- leucyl-L-leucyl-L-isoleucyl-L-leucylglycyl-L-alanyl-L-leucyl-L-leucyl-L- leucylglycyl- L-leucine
2.16.840.1.113883.3.6905.2
0‑L
100000169535
DESTILLATE OF MELISSA LEAF, CLOVE, ANGELICA ROOT, LAVENDER FLOWER, CINNAMON, NUTMEG FLOWER, NUTMEG SEED, CHINESE CINNAMON, SPEARMINT LEAF, PEPPERMINT LEAF, WORMWOOD, GENTIAN ROOT, CORIANDER FRUIT (9,1 : 7,6 : 5 : 2,5 : 2,5 : 2,5 : 2,5 : 2,5 : 1,5 : 1 : 1 : 1 : 1), DISTILLATION AGENT: ETHANOL 70% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000055873
S3.1,S3.6-cyclo[N-acetyl-3-sulfanyl-L-valyl-L-asparaginyl-L-threonyl-7- methyl-L-tryptophyl-N6-acetyl-L-lysyl-3-sulfanyl-L-valyl-O-(2- aminoethyl)-L-tyrosyl-3-(naphthalen-2-yl)-L-alanyl-4-aminooxan-4- carbonyl-L-alfa-glutamyl-L-asparaginyl-3-(pyridin-3-yl)-L-alanyl-N2- methylglycinamide] hydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000052140
Humanised IgG1 monoclonal antibody against HER2 conjugated to (2S)-2-((2-amino-2-methyl-propanoyl)amino)-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((1S)-2-phenyl-1-thiazol-2-yl-ethyl)amino)propyl)pyrrolidin-1-yl)-1-((1S)-1-methylpropyl)-4-oxo-butyl)-N,3-dimethyl-butanamide
2.16.840.1.113883.3.6905.2
0‑L
300000027131
Mixture of allergen extracts from Alopecurus pratensis, Cynosurus cristatus, Dactylis glomerata, Lolium perenne, Poa pratensis, Anthoxanthum odoratum, Festuca pratensis, Agrostis tenuis, Phleum pratense, Bromus spp., Arrhenatherum elatius, Holcus lanatus and Secale cereale, Glutaraldehyde-modified
2.16.840.1.113883.3.6905.2
0‑L
300000052175
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-hex-4-en-2-yl]-4,7,10,12,15,19,25,28-octamethyl-33-(methylamino)-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone hydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000056618
(4S)-4,11-Diethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl-N-{1-[4-({[(1R)-2-carboxy-1-(3-{3-[(propylcarbamoyl)amino]benzene-1-sulfonamido}phenyl)ethyl]carbamoyl}amino)anilino]-1-oxo-5,8,11-trioxa-2-azatetradecan-14-oyl}-L-alfa-aspartyl-L-prolyl-L-valinate
2.16.840.1.113883.3.6905.2
0‑L
300000044605
(2RS,12S)-14-[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110.14.03.5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]-7,7,11,12-tetramethyl-10,13-dioxo-2-sulfonyl-14-oxa-5,6-dithia-11-azatetradecanoic acid
2.16.840.1.113883.3.6905.2
0‑L
300000049039
Preparation of Symphytum x uplandicum herb (DER 0.2-0.9:1), composed of 40 % liquid extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid extract from the press residue after aqueous extraction of Symphytum x uplandicum herb, extraction solvent: ethanol 30 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000050922
Preparation of Symphytum x uplandicum herb (DER 0.5-0.7:1), composed of 40 % liquid extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid extract from the press residue after aqueous extraction of Symphytum x uplandicum herb, extraction solvent: ethanol 30 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000041430
(2Z,4S,6S,9R,10R,18S,21S,24R,25Z,27R,28R,30R,32S)-10,27-dihydroxy-21-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-4,28-dimethoxy-3,9,24,26,30,32-hexamethyl-34-phenyl-20,35,38-trioxa-13,34-diazatetracyclo[31.2.2.16,10.013,18]octatriaconta-2,25-diene-11,12,19,23,29-pentone
2.16.840.1.113883.3.6905.2
0‑L
300000042571
(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-15-[1-[(3-hydroxy-1,5-naphthyridin-4-yl)methyl]azetidin-3-yl]-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone (E)-but-2-enedioic acid
2.16.840.1.113883.3.6905.2
0‑L
300000001720
(1R,3R,15E,28R,29R,30R,31R,34R,36R,39S,41R)-29,41-difluoro-34,39-bis(sulfanyl)- 2,33,35,38,40,42-hexaoxa-4,6,9,11,13,18,20,22,25,27-decaaza-34delta5,39delta5-diphosphaoctacyclo[28.6.4.13,36.128,31.04,8.07,12.019,24.023,27]dotetraconta-5,7,9,11,15,19,21,23,25-nonaene-34,39-dione diammonia
2.16.840.1.113883.3.6905.2
0‑L
300000033240
S3,1, S3,6-Cyclo[N-acetyl-3-sulfanyl-L-valyl-L-asparaginyl-L-threonyl-7-methyl-L-tryptophyl-N6-acetyl-L-lysyl-3-sulfanyl-L-valyl-O-(2-aminoethyl)-L-tyrosyl-3-(naphthalen-2-yl)-L-alanyl-4-aminooxan-4-carbonyl-L-alpha-glutamyl-L-asparaginyl-3-(pyridin-3-yl)-L-alanyl-N2-methylglycinamide]
2.16.840.1.113883.3.6905.2
0‑L
300000055796
3-(1-(2-((S)-2-(3-Cyclopropyl-4-fluorophenyl)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-7-((S)-2,2-dimethyltetrahydro-2Hpyran-4-yl)indolizin-3-yl)cyclopropyl)-1,2,4-oxadiazol-5(4H)-one
2.16.840.1.113883.3.6905.2
0‑L
300000056939
(1R,2R,4S)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,32S,35R)-1,18-Dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-methyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-12-yl]propyl}-2-methoxycyclohexyl cyclohexanecarboxylate
2.16.840.1.113883.3.6905.2
0‑L
300000040432
[(1R)-1-[(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl-3-[(1R)-1-methoxyethyl]-4,9,10,12,16-pentamethyl-15-methylidene-2,5,8,11,14,17,20-heptaoxo-22-propan-2-yl-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-6-yl]-2-methylpropyl] (2S,3R)-3-hydroxy-4-methyl-2-(propanoylamino)pentanoate
2.16.840.1.113883.3.6905.2
0‑L
300000052174
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-hex-4-en-2-yl]-4,7,10,12,15,19,25,28-octamethyl-33-(methylamino)-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
2.16.840.1.113883.3.6905.2
0‑L
300000041793
N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysyl-L-aspartyl-L-alanyl-L-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-aspartyl-L-seryl-glycyl-L-tyrosyl-L-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysine, acetate salt
2.16.840.1.113883.3.6905.2
0‑L
300000027132
Mixture of allergen extracts from Alopecurus pratensis, Cynosurus cristatus, Dactylis glomerata, Lolium perenne, Poa pratensis, Anthoxanthum odoratum, Festuca pratensis, Agrostis tenuis, Phleum pratense, Bromus spp., Arrhenatherum elatius and Holcus lanatus, Glutaraldehyde-modified
2.16.840.1.113883.3.6905.2
0‑L
300000034814
L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-valyl-L-phenylalanylglycyl-L-isoleucyl-L-glutamyl-L-leucyl-L-methionyl-L-glutamyl-L-valyl-L-aspartyl-L-prolyl-L-isoleucylglycyl-L-histidyl-L-leucyl-L-tyrosyl-L-isoleucyl-L-phenylalanyl-L-alanyl-L-threonine
2.16.840.1.113883.3.6905.2
0‑L
300000054886
N-Acetyl-D-tyrosylglycyl-D-arginyl-D-lysyl-D-lysyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D-arginyl-D-arginylglycyl-D-lysyl-D-threonyl-D-leucyl-D-arginyl-D-valyl-D-alanyl-D-lysyl-D-alanyl-D-isoleucyl-D-tyrosyl-D-lysyl-D-arginyl-D-tyrosyl-D-isoleucyl-D-alfa-glutamine acetate
2.16.840.1.113883.3.6905.2
0‑L
300000050583
Gln-Gly-Pro-Pro-Leu-Met-Ala-Thr-Gln-Ser-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser
2.16.840.1.113883.3.6905.2
0‑L
100000139311
EXTRACTUM COMPOSITUM (1:1,3-1,6) EX: AGROPYRI RHIZOMATE 12,5 P.,ALLII CEPAE SQUAMA 5,0 P.,BETULAE FOLIO 10,0 P.,FOENUGRAECI SEMINE 15,0 P.,PETROSELINI RADICE 17,5 P.,SOLIDAGINIS HERBA 5,0 P., EQUISETI HERBA 10,0 P.,LEVISTICI RADICE 10,0 P.,POLYGONI AVICULARIS HERBA 15,0 P.
2.16.840.1.113883.3.6905.2
0‑L
300000054040
Liquid extract (DER 1:27,6-30,4) from roselle, carrot, couch grass rhizome, yarrow, angelica archangelica root, equisetum stem, ribwort plantain, juniper, chicory root, bitter orange epicarp and mesocarp (3:2,3:2,3:2,3:1,15:1,15:1,15:1,15:1:0,64), Extraction solvent: water
2.16.840.1.113883.3.6905.2
0‑L
300000052018
(12M)-(1S,2S)-N-((63S,4S,Z)-11-ethyl-12-(2-((S)-1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl)-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11H-8-oxa-2(4,2)-thiazola-1(5,3)-indola-6(1,3)-pyridazinacycloundecaphane-4-yl)-2-methylcyclopropane-1-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000004600
N-Acetyl-D-tyrosylglycyl-D-arginyl-D-lysyl-D-lysyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D-arginyl-D-arginylglycyl-D-lysyl-D-threonyl-D-leucyl-D-arginyl-D-valyl-D-alanyl-D-lysyl-D-alanyl-D-isoleucyl-D-tyrosyl-D-lysyl-D-arginyl-D-tyrosyl-D-isoleucyl-D-alfa-glutamine
2.16.840.1.113883.3.6905.2
0‑L
100000177278
N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysyl-L-aspartyl-L-alanyl-L-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-aspartyl-L-seryl-glycyl-L-tyrosyl-L-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysine
2.16.840.1.113883.3.6905.2
0‑L
100000133591
PLANT POLLEN ALLERGENS MIXTURE: SECALE CEREALE, AGROSTIS ALBA, ALOPECURUS PRATENSIS, ANTHOXANTHUM ODORATUM, APERA SPICA VENTI, ARRHENATHERUM ELATIUS, CYNOSURUS CRISTATUS, DACTYLIS GLOMERATA, FESTUCA PRATENSIS, HOLCUS LANATUS, LOLIUM PERENNE, PHLEUM PRATENSE, POA SP.
2.16.840.1.113883.3.6905.2
0‑L
100000141958
LIQUID EXTRACT (1:28,2) FROM: HIBISCUS FLOWER, BITTER FENNEL FRUITS, CARROTS, COUCH GRASS RHIZOME, YARROW, ANGELICA ROOT, EQUISETUM STEM, RIBWORT PLANTAIN, JUNIPER, CHICORY, BITTER ORANGE PEEL (3:2,3:2,3:2,3:2,3:1,15:1,15:1,15:1,15:1:0,64), EXTRACTION SOLVENT: WATER
2.16.840.1.113883.3.6905.2
0‑L
300000053858
Methyl(3as,4r,5ar,10br,13ar)-4-(acetyloxy)-3,5-epoxy-3a-ethyl-9-[(6r,8s)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methano-2h-azacyclodecino[4,3-b]indol-8-yl]-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-octahydro-3h-indolizino[8,1-cd]carbazole-5-carboxylate
2.16.840.1.113883.3.6905.2
0‑L
300000042372
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-Acetyloxy-12-(cyclopropanecarbonyloxy)-15-[(2R,3R)-3-(furan-2-yl)-2-hydroxy-3-(2-methylpropoxycarbonylamino)propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
2.16.840.1.113883.3.6905.2
0‑L
300000042520
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-acetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-4,4-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]oxy-4-methoxycarbonyloxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
2.16.840.1.113883.3.6905.2
0‑L
300000042539
(2S,3R)-2-acetamido-3-hydroxy-N-[(2R)-3-hydroxy-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]propan-2-yl]butanamide
2.16.840.1.113883.3.6905.2
0‑L
100000183927
ADENOVIRAL VECTOR OF SEROTYPE 5 MODIFIED TO CONTAIN A CHIMERIC SEQUENCE CONSISTING OF A MINIMAL UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR PROMOTER PRECEDED BY THREE NOTCH-RESPONSIVE ELEMENTS, AND COATED WITH OLIGOPEPTIDE END-MODIFIED POLY (BETA-AMINO) ESTERS
2.16.840.1.113883.3.6905.2
0‑L
300000034815
L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-methionyl-L-prolyl-L-phenylalanyl-L-alanyl-L-threonyl-L-prolyl-L-methionyl-L-glutamyl-L-alanyl-L-glutamyl-L-leucyl-L-alanyl-L-arginyl-L-arginyl-L-seryl-L-leucyl-L-alanine acetate salt
2.16.840.1.113883.3.6905.2
0‑L
100000183759
REFINED AND QUANTIFIED DRY EXTRACT OF GINKGO BILOBA DRIED LEAF (35-67:1), CORRESPONDING TO 13,2–16,2 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1,68–2,04 MG OF GINKGOLIDES A, B AND C, 1,56–1,92 MG OF BILOBALIDE, EXTRACTION SOLVENT: ETHANOL 59-65% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
100000145401
PREPARATION OF FRESH HERB OF SYMPHYTUM X UPLANDICUM (40% OF PRESSED JUICE OF FRESH HERB OF SYMPHYTUM X UPLANDICUM, DER 3-8:1, AND 60% OF AN EXTRACT OF THE PRESS RESIDUE FROM FRESH HERB OF SYMPHYTUM X UPLANDICUM, DER 3-10:1, EXTRACTION MEDIUM ETHANOL 30% V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000014580
Grass pollen allergen extract from Agrostis tenuis, Alopecurus pratensis, Anthoxanthum odoratum, Arrhenatherum elatius, Bromus inermis, Cynosurus cristatus, Dactylis glomerata, Festuca pratensis, Holcus lanatus, Lolium perenne, Phleum pratense, Poa pratensis
2.16.840.1.113883.3.6905.2
0‑L
300000032753
(1S,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E)-33-(((2S,3S,4S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,4,7,9,11,17,37-octahydroxy-15,16,18,36-tetramethyl-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-13-one
2.16.840.1.113883.3.6905.2
0‑L
300000044086
5-[4-[(2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]-5-oxopentanoic acid radioallebled with gallium-68
2.16.840.1.113883.3.6905.2
0‑L
300000008772
Refined and quantified dry extract of ginkgo biloba dried leaf (35-67:1), corresponding to 52,8–64,8 mg of flavonoids expressed as flavone glycosides, 6,72–8,16 mg of ginkgolides a, b and c, 6,24–7,68 mg of bilobalide, extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000004101
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of the mutated DnaE intein from Synechocystis sp. fused to the CEP290 body of the gene coding sequence and fused to the 5'-coding sequence of DnaB intein from Rhodothermus marinus
2.16.840.1.113883.3.6905.2
0‑L
300000015285
Refined and quantified dry extract of ginkgo biloba leaves (35-67:1) quantified to 22.0 to 27.0 % of flavonoids expressed as flavone glycosides, 2.8 to 3.4 % of ginkgolides a, b and c, and 2.6 to 3.2 % of bilobalide. extraction solvent: acetone 60% (m/m)
2.16.840.1.113883.3.6905.2
0‑L
300000042900
Clostridium botulinum A, strain CBAM0804 Hall-A, nontoxic-nonhaemagglutinin subunit fused to neurotoxin heavy chain fused to neurotoxin light chain fused to haemagglutinin 3b fused to haemagglutinin 1 fused to haemagglutinin 3a fused to haemagglutinin 2
2.16.840.1.113883.3.6905.2
0‑L
300000040031
Preparation of Symphytum officinale herb (DER 0.2 – 0.9 : 1), composed of 0.4 g of pressed juice from dried Symphytum officinale herb and 0.6 g of extract from the press residue of dried Symphytum officinale herb, Extraction solvent: ethanol 30% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
100000183970
(S)-2-isobutyrylamino-pentanedioic acid 5-amide 1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis-((S)-sec-butyl)-21-hydroxy-5-(4-hydroxy-benzyl)-15-isobutyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaaza-bicyclo[16.3.1]docos-12-yl]-amide}
2.16.840.1.113883.3.6905.2
0‑L
300000053934
(2S)-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(2S)-1-(4-aminophenyl)-3-azidopropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N,3-dimethylbutanamide
2.16.840.1.113883.3.6905.2
0‑L
100000142687
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY 5 MALIGE EXPONENTIATION WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS) (HAB, SV5B)
2.16.840.1.113883.3.6905.2
0‑L
300000011940
Refined and quantified dry extract from ginkgo leaf (35-67:1), 80 mg corresponding to 17,6-21,6 mg of flavonoids expressed as flavone glycosides, 2,2-2,7 mg of ginkgolides A, B and C, 2,1-2,6 mg of bilobalide, extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000041500
(3R,20r,24R,28S,34z,36S,38R,41S)-N-(cyclopropylsulfonyl)-9-methoxy-26,40,42-trioxo-4,25-dioxa-1,6,13,27,39-pentaazaheptacyclo(26.13.1.1(sup 3,41).0(sup 5,14).0(sup 7,12).0(sup 20,24).0(sup 36,38))tritetraconta-5,7,9,11,13,34-hexaene-38-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000037819
Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 17,6–21,6 mg of flavonoids expressed as flavone glycosides, 2,24–2,72 mg of ginkgolides A, B and C, 2,08–2,56 mg of bilobalide, Extraction solvent: ethanol 59-65% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000041017
1-((E)-4-((E)-5-carbamoyl-2-((1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)imino)-7-methoxy-2,3-dihydro-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-(methyl)-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazole-5-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000041467
Methyl N-[(2S)-1-[(2S)-4,4-difluoro-2-[5-[4-[2-[(5R)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-3,3-dimethyl-1,3-azasilolidin-5-yl]-3H-benzo[e]benzimidazol-7-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
2.16.840.1.113883.3.6905.2
0‑L
300000048053
Extract of lysates from Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus sanguinis, Streptococcus pyogenes, Klebsiella pneumoniae ssp. pneumoniae, Klebsiella pneumoniae ssp. ozaenae, Staphylococcus aureus and Moraxella catarrhalis
2.16.840.1.113883.3.6905.2
0‑L
300000034960
Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 26,4–32,4 mg of flavonoids expressed as flavone glycosides, 3,36–4,08 mg of ginkgolides A, B and C, 3,12–3,84 mg of bilobalide, Extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
100000142693
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO DIL. D12 AQUOS. (HAB, SV5B: SOLN=D6 PRODUCED BY 5 MALIGE POTENTIATION OF QUERCUS ROBUR/PETRAEAE CORTICE, DECOCTUM Ø (HAB VS.23A) WITH SATURATED AQUEOUS SOLUTION OF CALCAREAE CINERE QUERCUS)
2.16.840.1.113883.3.6905.2
0‑L
300000037378
Refined and quantified dry extract from ginkgo leaf (35-67:1), quantified to 17,6-21,6 mg of flavonoids expressed as flavone glycosides, 2,08-2,56 mg of bilobalide, 2,24-2,72 mg of ginkgolides a, b and c, Extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000039140
Refined and quantified dry extract from Ginkgo leaf (35-67:1), corresponding to 23.1- 28.4 mg of flavonoids expressed as flavone glycosides, 2.9-3.6 mg of ginkgolides A, B and C, 2.7-3.4 mg of bilobalide, Extraction solvent: acetone 60% M/M
2.16.840.1.113883.3.6905.2
0‑L
100000168633
GINKGO DRY EXTRACT (35-67:1), REFINED AND QUANTIFIED 80 MG CORRESPONDING TO: 17,6-21,6 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 2,2-2,7 MG OF GINKGOLIDES A, B AND C, 2,1-2,6 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 65% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000056177
Soft extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1), DER genuine 12-28: 1, First extraction solvent: water, acetone, sodium laurilsulfate (27:1:0.01 w/w/w), Second extraction solvent: acetone (100%)
2.16.840.1.113883.3.6905.2
0‑L
100000139510
EXTRACTUM COMPOSITUM EX: VALERIANA OFFICINALIS L., RADIX - 5 P.: MELISSA OFFICINALIS L., HERBA - 5 P.: ARCHANGELICA OFFICINALIS HOFFM., RADIX – 4 P.: HUMULUS LUPULUS L., STROBILUS – 3 P.: LAVANDULA OFFICINALIS CHAIX EX VILLARS, FLOS -3 P
2.16.840.1.113883.3.6905.2
0‑L
100000183099
VACCINIA VIRUS STRAIN ANKARA-BAVARIAN NORDIC-BRACHYURY CO-EXPRESSING THE BRACHYURY HUMAN TUMOR-ASSOCIATED ANTIGEN, THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3, THE HUMAN INTERCELLULAR ADHESION MOLECULE 1 AND THE HUMAN CD80 ANTIGEN
2.16.840.1.113883.3.6905.2
0‑L
300000052139
(2S)-2-((2-amino-2-methyl-propanoyl)amino)-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((1S)-2-phenyl-1-thiazol-2-yl-ethyl)amino)propyl)pyrrolidin-1-yl)-1-((1S)-1-methylpropyl)-4-oxo-butyl)-N,3-dimethyl-butanamide
2.16.840.1.113883.3.6905.2
0‑L
300000047578
[(1S,4S,6R,14S,18R)-18-[8-Chloro-7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-14-(cyclopentyloxycarbonylamino)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadecan-4-yl]-[(2,6-difluorophenyl)methyl]phosphinic acid
2.16.840.1.113883.3.6905.2
0‑L
100000131454
LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE KLEBSIELLA PNEUMONIAE AND OZAENAE STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PYOGENES AND VIRIDANS MORAXELLA (BRANHAMELLA / NEISSERIA) CATARRHALIS
2.16.840.1.113883.3.6905.2
0‑L
300000010520
Modified Vaccinia Ankara - Bavarian Nordic virus encoding the Ebola virus Zaire Mayinga strain glycoprotein, the Ebola virus Sudan strain glycoprotein, the Marburg virus Musoke strain glycoprotein and the Taï Forest virus nucleoprotein
2.16.840.1.113883.3.6905.2
0‑L
300000011742
Gly-Leu-Ala-Gly-Gly-Ser-Ala-Gln-Ser-Gln-Arg-Ala-Pro-Asp-Arg-Val-Leu-Cys-His-Ser-Gly-Gln-Gln-Gln-Gly-Leu-Pro-Arg-Ala-Ala-Gly-Gly-Ser-Val-Pro-His-Pro-Arg-Cys-Lys-Ile-Ser-Ile-Thr-Glu-Ile-Lys-Gly-Val-Ile-Val-His-Arg-Ile-Glu-Thr-Ile-Leu-Phe
2.16.840.1.113883.3.6905.2
0‑L
300000013341
Refined and quantified Ginkgo dry extract (35-67:1), corresponding to 8.80-10.80 mg of flavonoids expressed as flavone glycosides, 1.12-1.36 mg of ginkgolides A, B and C, 1.04-1.28 mg of bilobalide, extraction solvent: acetone 60% M/M
2.16.840.1.113883.3.6905.2
0‑L
100000139612
EXTRACTUM COMPOSITUM (1 : 1-1,2) EX: HIPPOCASTANI SEMINE – 27 P., BETAE ESCULENTA RADICE – 19 P., TILIAE FLORE – 15 P., FAGOPYRI HERBA – 12 P., CRATAEGI FOLIO CUM FLORE – 11 P., SOLIDAGINIS HERBA – 4 P.: EKSTRAHENT – ETANOL 60% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000047919
RNA (recombinant 5'-(m7G-5'-> 5')-ppp-Gm)-capped all uridine->N1-methylpseudouridine-substituted patient-specific neoantigen-specifying plus 5'-and 3'-untranslated flanking region-containing poly(A)-tailed messenger mRNA), inner salt
2.16.840.1.113883.3.6905.2
0‑L
100000166057
DISTILLATE OF LEMON BALM LEAVES, SAGE LEAVES, ROSEMARY LEAVES, THYME LEAVES, ANGELICA ROOT, NUTMEG SEEDS, CINNAMON, CLOVES AND LEMON (1: 0.125: 0.1: 0.083: 0.067: 0.042: 0.033: 0.017: 0.008), DISTILLATION AGENT: ETHANOL 70% (V / V)
2.16.840.1.113883.3.6905.2
0‑L
100000175579
Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
2.16.840.1.113883.3.6905.2
0‑L
300000034678
Humanised IgG1 monoclonal antibody against BCMA conjugated to 20-methyl-1-(3-methyl-3,9-dihydro-8H-dibenzo[b,f][1,2,3]triazolo[4,5-d]azocin-8-yl)-1,5,21- trioxo-8,11,14,17-tetraoxa-4,20-diazapentacosan-25-oyl desacetyl maytansinoid
2.16.840.1.113883.3.6905.2
0‑L
300000042919
Clostridium botulinum A, nontoxic-nonhaemagglutinin subunit fused to neurotoxin heavy chain fused to neurotoxin light chain fused to haemagglutinin 50 fused to haemagglutinin 33 fused to haemagglutinin 20 fused to haemagglutinin 17
2.16.840.1.113883.3.6905.2
0‑L
300000044090
DNA, D(P-thio)((2'-o-(2-methoxyethyl))RG-(2'-O-(2-methoxyethyl))RG-(2'-O-(2-methoxyethyl))m5ru-t-m5c-m5c-m5c-g-a-g-g-t-g-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))ra)
2.16.840.1.113883.3.6905.2
0‑L
300000049697
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-Acetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-4-methoxycarbonyloxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
2.16.840.1.113883.3.6905.2
0‑L
100000170413
SOFT EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS (30:1.5:1), DER: 12–28:1, FIRST EXTRACTION SOLVENT: WATER: ACETONE : SODIUM LAURILSULFATE (96:4:0.022 M/M/M), SECOND EXTRACTION SOLVENT: ACETONE
2.16.840.1.113883.3.6905.2
0‑L
100000145019
AQUEOS EXTRACT (1:15,6) FROM 2,5 G FROM A MIXTURE OF HAWTHORN LEAF AND FLOWER, VALERIAN ROOT, MELISSA LEAF, MISTLETOE, HOPS STROBILE, ROSEMARY LEAF, BITTER ORANGE PEEL, LAVENDER FLOWER (7:4:4:3:2:2:2:1), EXTRACTION LIQUID: WATER
2.16.840.1.113883.3.6905.2
0‑L
100000159582
DISTILLATE OF CARAWAY OIL, LAUREL OIL, CLOVE OIL, FENNEL OIL, ANISE OIL, EUCALYPTUS OIL, CINNAMON OIL, CAMPHOR, LEVOMANTHOL (12,07 : 1,32 : 10,11 : 9,58 : 4,89 : 2,42 : 1 : 6,53 : 4,05): DISTILLATION LIQUID: ETHANOL 47,5 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000050326
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoic acid
2.16.840.1.113883.3.6905.2
0‑L
300000042373
[2-methoxy-4-[(E)-3-(4-nitrooxybutoxy)-3-oxoprop-1-enyl]phenyl] (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate
2.16.840.1.113883.3.6905.2
0‑L
100000169108
DISTILLATE OF CINNAMON BARK, LEMON PEEL, CLOVE, ALLSPICE FRUIT, CARDAMOM SEED, JUNIPER BERRY, ANGELICA ROOT, GINGER ROOT, MELISSA LEAF, MACE (4 : 40 : 1,5 : 3 : 1 : 14 : 6 : 5 : 6 : 0,5), DISTILLATION AGENT: ETHANOL 78 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000027893
2-(3-{1-[1-(4-{[6-Amino-8-hydroxy-2-(2-methoxyethoxy)-9Hpurin-9-yl]methyl}phenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32-decaoxa-2-azatetratriacontan-34-yl]-1H-1,2,3triazole-4-yl}propanamido)ethyl 2,3-Bis(oleoyloxy)propyl phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000041343
N-[[(6aS,7R,13S,14S,16R)-5-(acetyloxy)-6,6a,7,13,14,16-hexahydro-8,14-dihydroxy-9-methoxy-4,10,17-trimethyl-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocin-16-yl]methyl]-3-[3-(trifluoromethyl)phenyl]-2E-propenamide
2.16.840.1.113883.3.6905.2
0‑L
300000042682
[(3S)-1-[[(2R,3R,4R,5S,6R)-2-[[(2R,3S,4R,5R,6R)-3,4-dihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]-6-phosphonooxyoxan-2-yl]methoxy]-4-hydroxy-6-(hydroxymethyl)-5-phosphonooxyoxan-3-yl]amino]-1-oxotetradecan-3-yl] dodecanoate
2.16.840.1.113883.3.6905.2
0‑L
300000048061
Immunoglobulins against Escherichia coli, Salmonella dublin, Salmonella enteritidis, Salmonella typhimurium, Salmonella rostock, Salmonella abortusequi, Streptococcus pneumoniae, Streptococcus equi subsp. zooepidemicus, Equine
2.16.840.1.113883.3.6905.2
0‑L
300000052035
2-((S)-4-((S)-7-(3-Amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl)-2-(((2r,7as)-2-fluorotetrahydro-1h-pyrrolizin-7a(5h)-yl)methoxy)-7,8-dihydro-5h-pyrano(4,3-d)pyrimidin-4-yl)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile
2.16.840.1.113883.3.6905.2
0‑L
100000170041
DISTILLATE (1 : 12) FROM PEPPERMINT LEAF, ANISEED, LAVENDER FLOWER, BITTER FENNEL FRUIT, SAGE LEAF, WORMWOOD, CENTAURY, ELECAMPANE RHIZOME (8,33 : 5 : 5 : 3,33 : 1,67 : 1,67 : 1,67 : 1), DISTILLATION AGENT: ETHANOL 34 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000042058
N-[(2R)-1-[(2S)-2-[(3-hydroxy-2-methyl-6-{[(3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}oxan-4- yl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]pyridine-4-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000042371
(4aS,6aR,6aR,6bR,8aR,12aR,14bS)-6a-[[(E)-3-[2-[[(E)-3-carboxyprop-2-enoyl]amino]-5-hydroxyphenyl]prop-2-enoyl]oxymethyl]-2,2,6b,9,9,12a-hexamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000042779
L-Lysylglycyl-L-isoleucyl-L-methionyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-seryl-L-leucyl-L-valyl-L-arginyl-L-leucyl-L-seryl-L-seryl-L-cysteinyl-L-valyl-L-prolyl-L-valyl-L-alanyl-L-leucyl-L-methionyl-L-seryl-L-alanine acetate
2.16.840.1.113883.3.6905.2
0‑L
100000158061
EXTRACTUM SICCUM COMPOSITUM (4- 9 : 1) EX BAPTISIAE TINCTORIAE L. RADIX 4,92 P., ECHINACEAE PURPUREAE (L.) MOENCH RADIX 1,85 P., ECHINACEAE PALLIDAE NUTT. RADIX 1,85 P., THUJAE OCCIDENTALIS L. HERBA 1 P., ETHANOL 30 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000045868
Dry extract refined from Birch bark, equivalent to 0.5-1.0 g birch bark, including 84-95 mg triterpenes calculated as the sum of betulin, betulinic acid, erythrodiol, lupeol and oleanolic acid, Extraction solvent: n-heptane
2.16.840.1.113883.3.6905.2
0‑L
100000181070
(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-o-[alpha-(2'', 4'', 5'', 7''-tetranitro-9''-fluorenylideneaminooxy)propionyl]-1h-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4h), 12h)-dione, hydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000008826
[4-aminobutanoic acid-glycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-L-aspartyl](cyclo 1-Dgamma17)
2.16.840.1.113883.3.6905.2
0‑L
300000018720
(3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000052878
[(1S,2S,3R,4S,7R,8S,9R,10S,12R,15S)-4,12-Diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,8,9-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
2.16.840.1.113883.3.6905.2
0‑L
100000175246
Methyl (15S,16R,18R)-10,23-bis(ethylsulfanylmethyl)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate
2.16.840.1.113883.3.6905.2
0‑L
300000003820
(6S,9aS)-8-((6-(3-(4-ethyl-1-piperazinyl)-1-azetidinyl)-2-pyridinyl)methyl)-6-((2-fluoro-4-hydroxyphenyl)methyl)hexahydro-4,7-dioxo-N-(phenylmethyl)-2-(2-propen-1-yl)-2h-pyrazino(2,1-c)(1,2,4)triazine-1(6h)-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000026033
Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human claudin 18.2 antigen with CD28 and CD3-zeta intracellular signalling domains
2.16.840.1.113883.3.6905.2
0‑L
100000175616
N-[2-(dimethylamino)ethyl]-2-{[26,27,28-tris({[2-(dimethylamino)ethyl]carbamoyl}methoxy)pentacyclo[19.3.1.1^{3,7}.1^{9,13}.1^{15,19}]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaen-25-yl]oxy}acetamide
2.16.840.1.113883.3.6905.2
0‑L
300000042778
L-Lysylglycyl-L-isoleucyl-L-methionyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-seryl-L-leucyl-L-valyl-L-arginyl-L-leucyl-L-seryl-L-seryl-L-cysteinyl-L-valyl-L-prolyl-L-valyl-L-alanyl-L-leucyl-L-methionyl-L-seryl-L-alanine
2.16.840.1.113883.3.6905.2
0‑L
100000181834
5-(2,6-difluoro-phenoxy)-3(R,S)-(2(S)-(2(S)-(3-methoxycarbonyl-2(S)-(3-methyl-2(S)-((quinoline-2-carbonyl)-amino)-butyrylamino)-propionylamino)-3-methyl-butyrylamino)-propionylamino)-4-oxo-pentanoic acid methyl ester
2.16.840.1.113883.3.6905.2
0‑L
100000182408
LIQUID EXTRACT FROM ONOPORDUM ACANTHIUM FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99 PARTS OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB [(DER 1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)]
2.16.840.1.113883.3.6905.2
0‑L
300000032600
(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethylcarbamoyl)-quinolin-6-yl)(methyl)amino)-propyl)piperazin-1-yl)-2-oxoethyl)-68Ga-[1,4,7,10]-tetraazacyclododecane-1,4,7-triyl)triacetate
2.16.840.1.113883.3.6905.2
0‑L
100000139507
EXTRACTUM COMPOSITUM (ET. 96% V/V, 1:7,5) EX: SOENI, SALICIS CORTICE, POLYGONI AVICULARIS HERBA, EQUISETI HERBA, MILLEFOLII HERBA, CHAMOMILLAE ANTHODIO, CALENDULAE ANTHODIO, SAPONARIAE RADICE (25:10:4:4:2:2:1,5:1,5)
2.16.840.1.113883.3.6905.2
0‑L
300000010761
2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide, tetrahydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000054163
2-[4,7-Bis(carboxymethyl)-10-[2-[4-[3-[[4-[[2-[(2S)-2-cyano-4,4-difluoropyrrolidin-1-yl]-2-oxoethyl]carbamoyl]quinolin-6-yl]-methylamino]propyl]piperazin-1-yl]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
2.16.840.1.113883.3.6905.2
0‑L
100000174814
LIQUID EXTRACT FROM A MIXTURE (4.7:1) OF MATRICARIA CAPITULA AND RAY FLORETS (DER 1:4.0-4.5), EXTRACTION SOLVENTS: ETHANOL 96% (V/V), PURIFIED WATER, SODIUM ACETATE TRIHYDRATE, SODIUM ASCORBATE AND SODIUM HYDROXIDE
2.16.840.1.113883.3.6905.2
0‑L
100000175117
(1S,4R,6S,7E,18S)-18-[7-Methoxy-8-methyl-2-[4-(trifluoromethyl)-1,3-thiazol-2-yl]quinolin-4-yl]oxy-13-methyl-N-(1-methylcyclopropyl)sulfonyl-2,14-dioxo-3,13,15-triazatricyclo[13.4.0.04,6]nonadec-7-ene-4-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000021703
Refined and quantified dry extract from Vaccinium macrocarpon fruit juice (20-35:1), corresponding to 36 mg (34.2-37.8 mg) of proanthocyanidins expressed as proanthocyanidins A2, extraction solvent: ethanol 70% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000041389
Cyanomethyl (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2,2,3,3-tetramethylcyclopropanecarbonyl)oxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxylate
2.16.840.1.113883.3.6905.2
0‑L
300000050600
(2S,5S,6S)-2-[(S)-[(2S,3R,4S,5R)-5-(Aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-6-hydroxy-1,4-dimethyl-3-oxo-1,4-diazepane-5-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000024246
17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
100000133323
GRASS POLLEN ALERGOIDS MIXTURE: ALOPECURUS PRATENSIS, ANTHOXANTHUM ODORATUM, ARRHENATHERUM ELATIUS, DACTYLIS GLOMERATA, FESTUCA PRATENSIS, HOLCUS LANATUS, LOLIUM PERENNE, PHLEUM PRATENSE, POA SP., SECALE CEREALE
2.16.840.1.113883.3.6905.2
0‑L
100000174755
EXTRACT (1:12.4) OF HAWTHORN LEAF AND FLOWER, VALERIAN ROOT, MELISSA LEAF, MISTLETOE, HOP STROBILE, ROSEMARY LEAF, BITTER-ORANGE EPICARP AND MESOCARP, LAVENDER FLOWER (7:4:4:3:2:2:2:1), EXTRACTION SOLVENT: WATER
2.16.840.1.113883.3.6905.2
0‑L
100000183100
FOWLPOX VIRUS STRAIN TBC-FPV CO-EXPRESSING THE BRACHYURY HUMAN TUMOR-ASSOCIATED ANTIGEN, THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3, THE HUMAN INTERCELLULAR ADHESION MOLECULE 1 AND THE HUMAN CD80 ANTIGEN
2.16.840.1.113883.3.6905.2
0‑L
300000048802
(2S)-5-(Diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]pentanoic acid
2.16.840.1.113883.3.6905.2
0‑L
100000182409
LIQUID EXTRACT FROM PRIMULA VERIS FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99 PARTS OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB [(DER 1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)]
2.16.840.1.113883.3.6905.2
0‑L
100000184027
DRY EXTRACT (DER 3-6:1) FROM GINSENG ROOT, ATRACTYLODES LANCEA RHIZOME, PORIA, PINELLIA TERNATA ROOT, TANGERINE, JUJUBE FRUIT, LICORICE AND GINGER (2 : 2 : 2 : 2 : 1 : 1 : 0.5 : 0.25), EXTRACTION SOLVENT: WATER
2.16.840.1.113883.3.6905.2
0‑L
300000045554
Allogeneic non-alloreactive T cells edited with mRNA to disrupt TRAC and CD52 genes and transduced with a lentiviral vector to express two chimeric antigen receptors independently directed against CD20 and CD22
2.16.840.1.113883.3.6905.2
0‑L
300000051008
Bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl](2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
2.16.840.1.113883.3.6905.2
0‑L
300000018771
S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide) acetate
2.16.840.1.113883.3.6905.2
0‑L
300000038847
((Trans)-4-((2-(((2-chloro-4-((((R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)carbamoyl)oxy)ethyl)(methyl)amino)cyclohexyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate
2.16.840.1.113883.3.6905.2
0‑L
300000051768
1-(1-oxooctyl)-L-prolyl-L-cysteinyl-L-lysyl-L-asparaginyl-2,4,6-trimethyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteinyl-L-lysine, (2->13)-disulfide
2.16.840.1.113883.3.6905.2
0‑L
100000172864
8-(3-((2-(4-AMINOPHENYL)-7-METHOXY-5-OXO-1,11A.BETA.-DIHYDRO-5H-PYRROLO(2,1-C)(1,4)BENZODIAZEPINE-8-YL)OXY)PROPOXY)-7-METHOXY-2-(4-METHOXYPHENYL)-1,11A.BETA.-DIHYDRO-5H-PYRROLO(2,1-C)(1,4)BENZODIAZEPINE-5-ONE
2.16.840.1.113883.3.6905.2
0‑L
300000043000
Soft extract of crude pollen of Secale cereale, Phleum pratense and Zea mays (30:1.5:1), First extraction solvent: Water:acetone:sodium laurilsulfate (27:1:0.01 w/w), Second extraction solvent: acetone (100%)
2.16.840.1.113883.3.6905.2
0‑L
300000047577
1-(4-tert-butylphenyl)sulfonyl-3-[(3R)-3-[(3S,5R,6R,7R,8R,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]urea
2.16.840.1.113883.3.6905.2
0‑L
300000036064
Modified vaccinia Ankara - Bavarian Nordic virus, expressing Respiratory syncytial virus glycoprotein strain A2, glycoprotein strain B, nucleocapsid protein, matrix protein, fusion protein strain Along, Live
2.16.840.1.113883.3.6905.2
0‑L
300000021735
[(3As,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
2.16.840.1.113883.3.6905.2
0‑L
300000014040
S-[(2R)-2,3-Dipalmitoyloxypropyl]-L-cysteinylglycyl-L-asparaginyl-L-asparaginyl-L-alpha-aspartyl-L-alpha-glutamyl-L-seryl-L-asparaginyl-L-isoleucyl-L-seryl-L-phenylalanyl-L-lysyl-L-alpha-glutamyl-L-lysine
2.16.840.1.113883.3.6905.2
0‑L
300000053846
3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxopyridin-1-yl]-N-[4-[1-[4-[4-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]butylamino]-4-oxobutyl]triazol-4-yl]butyl]-4-methylbenzamide
2.16.840.1.113883.3.6905.2
0‑L
300000055678
2-{[2-({(2S)-4-carboxy-1-[4-({4-[11β-hydroxy-3,20-dioxo-21-(phosphonooxy)-2'H,16βH-[1,3]dioxolo[4',5':16,17]pregna-1,4-dien-2'αyl]phenyl}methyl)anilino]-1-oxobutan-2-yl}amino)-2-oxoethyl]amino}-2-oxoethyl
2.16.840.1.113883.3.6905.2
0‑L
300000039588
Adeno-associated viral vector serotype 8 encoding B-domain deleted liver specific codon optimized bioengineered chimeric human porcine factor VIII, under a synthetic hepatic combinatorial bundle promoter
2.16.840.1.113883.3.6905.2
0‑L
300000043585
Dry standardised extract from milk thistle fruit equivalent to 3325 mg – 9720 mg of milk thistle fruit corresponding to 108 mg of silymarin calculated as silibin, Extraction solvent: acetone 99.9 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000056648
Liquid extract (1:11) from Marshmallow root, Chamomile flower, roman, Equisetum stem, Juglans regia leaf, Yarrow, Oak bark, Dandelion herb with root (4:3:5:4:4:2:4), Extraction solvent: ethanol 59% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000024717
N-carboxymethyl-glycyl-L-threonyl-L-histidyl-L-3,3-diphenylalanyl-L-piperidincarboxy-3-yl-L-arginyl-L-S-methylthio-cystyl-L-arginyl-L-tryptophyl-aminohexanyl-N-carboxamidomethyl-glycine N-hexadecylamide
2.16.840.1.113883.3.6905.2
0‑L
300000026911
Allogeneic non-alloreactive T cells edited with mRNA to disrupt TRAC and CD52 genes and transduced with lentiviral vector expressing a chimeric antigen receptor against CD22 and RQR8 depletion mechanism
2.16.840.1.113883.3.6905.2
0‑L
300000032498
Hop strobile oleoresin, corresponding to 3.36 g potassium hop beta acids, expressed as potassium lupulone, potassium adlupulone and potassium colupulone, Extraction solvent: supercritical carbon dioxide
2.16.840.1.113883.3.6905.2
0‑L
300000003598
Dry extract from rhubarb root (30-70 parts) and rheum australe root (30-70 parts), corresponding to 4.3-5.3 mg of hydroxyanthracene derivatives, calculated as rhine, extraction solvent: ethanol 90% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000006102
S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)
2.16.840.1.113883.3.6905.2
0‑L
300000017080
3-amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide dihydrochloride chloride
2.16.840.1.113883.3.6905.2
0‑L
300000024245
(2R)-2-[5-[3-Chloro-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy-3-[2-[[2-[2-(hydroxymethyl)phenyl]pyrimidin-4-yl]methoxy]phenyl]propanoic acid
2.16.840.1.113883.3.6905.2
0‑L
300000056630
3-(3-carboxypropyl)-2-[2-[3-[2-[1,3-dihydro-3,3-dimethyl-1-(3-sulfopropyl)-2H-indol-2-ylidene]ethylidene]-2-(4-sulfophenoxy)-1-cyclohexen-1-yl]ethenyl]-3-methyl-1-(3-sulfopropyl)-3H-indolium inner salt
2.16.840.1.113883.3.6905.2
0‑L
300000008877
(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alfa-(2", 4", 5", 7"-tetranitro-9"-fluorenylideneaminooxy)propionyl]-1H-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4H, 12H)-dione
2.16.840.1.113883.3.6905.2
0‑L
300000054910
(2R)-4-[2-[4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-ethylphenoxy]ethyl]-N-[3-[[(3R)-2,6-dioxo-3-piperidinyl]amino]phenyl]-2-methyl-1-piperazineacetamide
2.16.840.1.113883.3.6905.2
0‑L
100000159897
EXTRACT (1:38) FROM MARSHMALLOW ROOT, OAK BARK, CAMOMILE FLOWERS, DANDELION HERB, HORSETAIL HERB, YARROW HERB AND WALNUT LEAVES (4:2:3:4:5:4:4), EXTRACTION SOLVENTS: ETHANOL 59% (V/V), PURIFIED WATER
2.16.840.1.113883.3.6905.2
0‑L
300000027196
Liquid extract (0.67:1) from: Artemisia abrotanum herb, milk thistle fruit, peppermint leaf, Centaurea benedicta herb, dandelion root and yarrow (35/15/8/3/3/3), Extraction solvent: ethanol 70% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000041472
3-((4-((4-((((5-(1,1-dimethylethyl)-2-methoxy-3-((methylsulfonyl)amino)phenyl)amino)carbonyl)amino)-1-naphthalenyl)oxy)-2-pyrimidinyl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide
2.16.840.1.113883.3.6905.2
0‑L
100000139505
EXTRACTUM LIQUIDUM (ET. 75% V/V, 1:2) EX: PHASEOLI PERICARPIO, BARDANAE RADICE, SAMBUCI FRUCTU, EQUISETI HERBA, RHEI RADICE, FAGOPYRI HERBA, ONONIDIS RADICE, BETULAE FOLIO ( 30:20:15:10:7,5:7,5:5:5)
2.16.840.1.113883.3.6905.2
0‑L
300000038210
Turkey herpesvirus, strain HVT/IBD/ILT (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis virus, Live
2.16.840.1.113883.3.6905.2
0‑L
300000047463
[(1S,9R,18R,19S,21R,22S)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.18,11.04,9.010,15]tricosa-4,10,12,14-tetraen-19-yl] 3,4,5-trihydroxybenzoate
2.16.840.1.113883.3.6905.2
0‑L
100000175242
(6aS)-3-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one
2.16.840.1.113883.3.6905.2
0‑L
300000041445
(2R)-2-(((3R)-3-(1,3-benzodioxol-5-yl)-3-(((6-methoxy-2-naphthyl)sulfonyl)amino)propanoyl)amino)-3-(4-(((2R,6S)-2,6-dimethylpiperidinyl)methyl)phenyl)-N-isopropyl-N-methylpropanamide hydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000041506
Methyl N-[(1S,2S)-1-(4-chlorophenyl)-1-(3,5-difluorophenyl)-3-[[5-fluoro-4-[2-[(2R,5S)-5-(2,2,2-trifluoroethylcarbamoyloxymethyl)morpholin-2-yl]ethyl]pyridin-3-yl]amino]-3-oxopropan-2-yl]carbamate
2.16.840.1.113883.3.6905.2
0‑L
300000041871
L-Aspartyl-L-leucyl-L-arginyl-L-glutaminyl-L-methionyl-L-arginyl-L-threonyl-L-valyl-L-threonyl-L-prolyl-L-isoleucyl-L-arginyl-L-methionyl-L-glutaminyl-glycyl-glycyl-L-seryl-glycyl-L-serine acetate
2.16.840.1.113883.3.6905.2
0‑L
300000042699
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-1-[[3-(2-hydroxypropan-2-yl)phenyl]methoxy]propan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
2.16.840.1.113883.3.6905.2
0‑L
300000051516
4-[4-[(R)-[2-(4-Chlorophenyl)phenyl]-hydroxymethyl]piperidin-1-yl]-N-[4-[[(2R)-4-[2-hydroxyethyl(methyl)amino]-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide
2.16.840.1.113883.3.6905.2
0‑L
300000054656
(6aS)-3-[5-[[(6aS)-2-Methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one
2.16.840.1.113883.3.6905.2
0‑L
100000143487
STYRENE-BUTADIENE-STYRENE (SBS) AND STYRENE-BUTADIENE BLOCK CO-POLYMERS, COLOPHONIUM RESIN, ANTIOXIDANTS (2,4-BIS(1,1-DIMETHYLETHYL)PHENYL PHOSPHITE (3:1), TRIS(2,4-DI-TERT-BUTYLPHENYL)PHOSPHATE)
2.16.840.1.113883.3.6905.2
0‑L
100000174332
LIQUID EXTRACT OF ICELAND MOSS, SAPONARIA OFFICINALIS ROOT, PIMPINELLA ROOT, EUCALYPTUS LEAF, FENNEL BITTER FRUIT (1:1:1:1:1) AND 1 PART OF STAR ANISE (1:3-4), EXTRACTION SOLVENT: ETHANOL 30% V/V
2.16.840.1.113883.3.6905.2
0‑L
100000176534
LIQUID EXTRACT (0,65:1) FROM A MIXTURE OF: MATRICARIA FLOWER, OAK BARK, SAGE LEAF, ARNICA HERB, CALAMUS RHIZOME, PEPPERMINT HERB, THYME HERB (2:2:2:1:1:1:1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000010760
2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide
2.16.840.1.113883.3.6905.2
0‑L
300000013167
Dry extract from tinnevelly senna pods and alexandrian senna pods (4.5-5.5:1), 100-166.5 mg corresponding to 10 mg hydroxyanthracene glycosides, calculated as sennoside B, extraction agent: water
2.16.840.1.113883.3.6905.2
0‑L
300000027651
Allogeneic bone marrow-derived haematopoietic stem and progenitor cells treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor
2.16.840.1.113883.3.6905.2
0‑L
300000027671
Autologous bone marrow-derived haematopoietic stem and progenitor cells treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor
2.16.840.1.113883.3.6905.2
0‑L
300000052870
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] propanoate
2.16.840.1.113883.3.6905.2
0‑L
300000054065
Autologous peripheral blood-derived CD4 and CD8 T lymphocytes, transduced with a lentiviral vector to expressing a chimeric receptor against BCMA with co-stimulatory sequences 4-1-BB and CD3 zeta
2.16.840.1.113883.3.6905.2
0‑L
300000054302
5-[5-Chloro-2-[(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-N-(5-cyano-1,2-dimethylpyrrol-3-yl)-N-(4-hydroxyphenyl)-1,2-dimethylpyrrole-3-carboxamide sulfuric acid
2.16.840.1.113883.3.6905.2
0‑L
300000039898
(7S,9S)-6,9,11-Trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-7-[[(2S,4R,6S,7S,9R,10S)-10-methoxy-6-methyl-5,8,11-trioxa-1-zatricyclo[7.4.0.02,7]tridecan-4-yl]oxy]-8,10-dihydro-7H-tetracene-5,12-dione
2.16.840.1.113883.3.6905.2
0‑L
300000041328
1,5-anhydro-2,3-dideoxy-4-o-methyl-3-(((1R,3S)-3-(1-methylethyl)-3-(((1S,4S)-5-(6-(trifluoromethyl)-4-pyrimidinyl)-2,5-diazabicyclo(2.2.1)hept-2-yl)carbonyl)cyclopentyl)amino)-d-erythro-pentitol
2.16.840.1.113883.3.6905.2
0‑L
300000017100
3-amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide trifluoroacetate
2.16.840.1.113883.3.6905.2
0‑L
300000028552
Turkey herpesvirus, strain HVT/NDV/ILT (cell-associated), expressing fusion protein gene of Newcastle disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis virus, Live
2.16.840.1.113883.3.6905.2
0‑L
300000041116
Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), strain 3014 and serotype O9:K35 (fimbrial adhesin F5), strain 3015 and serotype O101:K30 (fimbrial adhesin F5), strain 3016, Inactivated
2.16.840.1.113883.3.6905.2
0‑L
300000046889
Dry extract from milk thistle fruit, (equivalent to 3.725 g – 10.818 g of milk thistle fruits) corresponding to 108 mg of silymarin, calculated as silibinin. extraction solvent: acetone 95% v/v
2.16.840.1.113883.3.6905.2
0‑L
300000047854
(2S)-2-[(Z)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S)-3-methyl-1-oxo-3-(sulfooxyamino)butan-2-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-[N'-[(3R)-piperidin-3-yl]carbamimidoyl]phenoxy]propanoic acid
2.16.840.1.113883.3.6905.2
0‑L
300000041681
H-Lys-Val-Ala-Glu-Leu-Val-His-Phe-Leu-Arg-Val-Lys-Arg-Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val-Arg-Val-Lys-Arg-Val-Ile-Phe-Ser-Lys-Ala-Ser-Ser-Ser-Leu-Gln-Leu-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH
2.16.840.1.113883.3.6905.2
0‑L
300000044662
Polypeptide consisting of a glucagon-like peptide-1 receptor agonist and an amylin receptor agonist, connected by a linker with 4 glycine residues, and connected to a C18 fatty acid side chain
2.16.840.1.113883.3.6905.2
0‑L
300000052865
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2.16.840.1.113883.3.6905.2
0‑L
300000052885
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2.16.840.1.113883.3.6905.2
0‑L
300000054371
(2S)-N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-2-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)thioxomethyl]-1-pyrrolidinecarboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000055878
Dry extract of Ginkgo leaf (40-50:1), corresponding to 17.6-21.6 mg of flavone glycosides, 2.2-2.7 mg of ginkgolides A, B and C, 2.1-2.6 mg of bilobalide, Extraction solvent: ethanol 50% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
100000177418
(R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-(1,2,4)triazolo(4,3-a)pyrimidin-5-yl)phenyl)-n,n,n-trimethylethanaminium methanesulfonate
2.16.840.1.113883.3.6905.2
0‑L
100000177427
Human donor haematopoietic stem and progenitor cells that have been treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor
2.16.840.1.113883.3.6905.2
0‑L
300000037858
Liquid extract from fresh Purple coneflower root corresponding to 15-21 mg of fresh purple solhatt root, equivalent to 4 mg of dried purple solhatt root, Extraction solvent: ethanol 57.3% M/M
2.16.840.1.113883.3.6905.2
0‑L
300000039488
Liquid extract from a mixture (2.5: 2.5: 1) of thyme, wild thyme, Ribwort plantain (DER 1:2.9-3.3), Extraction solvent: glycerol 85% M/M, ethanol 96% V/V and purified water (1:7.5:31.2 m/m/m)
2.16.840.1.113883.3.6905.2
0‑L
300000047583
5-[5-chloro-2-[[(3S)-3,4-dihydro-3-(4-morpholinylmethyl)-2(1H)-isoquinolinyl]carbonyl]phenyl]-N-(5-cyano-1,2-dimethyl-1H-pyrrol-3-yl)-N-(4-hydroxyphenyl)-1,2-dimethyl-1H-Pyrrole-3-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000047713
Plasmid DNA which encoding a human IgG1 antibody molecule containing a epitope derived from the TRP-2 melanoma antigen plus two helper T-cell sequences derived from the melanoma gp100 protein
2.16.840.1.113883.3.6905.2
0‑L
300000048052
(S)-4-(4-(3-Chloro-4-(1-(5-fluoropyridin-2-yl)-2-hydroxyethoxy)pyrazolo[1,5-a]pyridin-6-yl)-5-methyl-1H-1,2,3-triazol-1-yl)piperidine-1-carbonitrile hemi-3,4,5-trihydroxybenzoate hemi-hydrate
2.16.840.1.113883.3.6905.2
0‑L
300000051643
7-[4-Methyl-6-(2-methylpropyl)pyridin-3-yl]-6-oxo-N-[(1R,2S)-2-(prop-2-enoylamino)cyclopentyl]-2-thia-5,7,11-triazatricyclo[6.3.1.04,12]dodeca-1(11),3,8(12),9-tetraene-3-carboxamide dihydrate
2.16.840.1.113883.3.6905.2
0‑L
300000051797
Potassium sodium 4-[[2-(3-carboxylatopropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate hydrate
2.16.840.1.113883.3.6905.2
0‑L
300000034925
H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Try-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Cys-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Cys-lle-lle-Gly-Leu-Met-Val-Gly-Gly-Val-Val-lle-Ala-OH hexahydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000046998
Dry extract from milk thistle fruit (equivalent to 1.721 g – 5.000 g of milk thistle fruits) corresponding to 50 mg of silymarin, calculated as silibinin. Extraction solvent, acetone 95% v/v
2.16.840.1.113883.3.6905.2
0‑L
300000054349
(2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-[[(3R,5R,8R,9R,10S,13S,14S)-13-methyl-17-oxo-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000056176
Dry extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1), DER genuine 2.7-7.5:1, Extraction solvents: water, acetone, sodium laurilsulfate (27:1:0.01 w/w/w)
2.16.840.1.113883.3.6905.2
0‑L
100000170412
DRY EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS (30:1.5:1), DER: 2.7-7.5:1, EXTRACTION SOLVENT: WATER : ACETONE : SODIUM LAURILSULFATE (96:4:0.022 M/M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000011554
Dry standardised extract from milk thistle fruit equivalent to 8100 g of milk thistle fruit corresponding to 174 mg of silymarin calculated as silibin, extraction solvent: acetone 95% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000025380
N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-N1-methyl-L-tryptophyl-L-glutaminyl-L-alpha-aspartyl-L-tryptophyl-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threoninamide (2->12)-disulfide
2.16.840.1.113883.3.6905.2
0‑L
300000042459
(8R,9S,10R,11S,13S,14S,17S)-17-(3,3-dimethylbut-1-ynyl)-17-hydroxy-13-methyl-11-[4-[methyl(propan-2-yl)amino]phenyl]-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
2.16.840.1.113883.3.6905.2
0‑L
300000042468
(3S)-3-methylsulfanyl-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxypyridin-3-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000046719
L-Aspartyl-L-leucyl-L-arginyl-L-glutaminyl-L-methionyl-L-arginyl-L-threonyl-L-valyl-L-threonyl-L-prolyl-L-isoleucyl-L-arginyl-L-methionyl-L-glutaminyl-glycyl-glycyl-L-seryl-glycyl-L-serine
2.16.840.1.113883.3.6905.2
0‑L
300000054989
Autologous CD34+ cell enriched population that contains haematopoietic stem and progenitor cells transduced ex vivo using a replication-incompetent lentiviral vector encoding the NOD2 gene
2.16.840.1.113883.3.6905.2
0‑L
300000018872
Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, New-Jersey serotype, encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax, HBZ, p12I and p30II
2.16.840.1.113883.3.6905.2
0‑L
300000011920
(3R)-1-[[7-cyano-2-[3-[3-[[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]-2-methylphenyl]-2-methylphenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000038503
3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-2,4,6,8(13)-tetraen-3-yl]-4-{imidazo[1,2-a]pyridin-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione ethanol solvate
2.16.840.1.113883.3.6905.2
0‑L
300000046629
3-(2-((1R,4aS,5R,8aS)-5,8a-dimethyl-2-methylene-5-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)decahydronaphthalen-1-yl)ethyl)furan-2(5H)-one
2.16.840.1.113883.3.6905.2
0‑L
100000170280
EXTRACT (1:5,5-5,9) OF MATRICARIA FLOWER AND YARROW (2,4:1), EXTRACTION SOLVENT: ETHANOL 96 %, PURIFIED WATER, AMMONIA SOLUTION 10 %, MACROGOLGLYCEROL HYDROXYSTEARATE (52,1:50,8:1:0,25)
2.16.840.1.113883.3.6905.2
0‑L
300000038279
N-{3-fluoro-4-[(3-{[(2R)-1-hydroxypropan-2-yl]amino}-1H-pyrazolo[3,4- b]pyridin-4-yl)oxy]phenyl}-3-(4-fluorophenyl)-2,4-dioxo-1-(propan-2-yl)- 1,2,3,4-tetrahydropyrimidine-5-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
100000134946
LIQUID EXTRACT FROM A MIXTURE OF PLANTAGO LANCEOLATA LEAF AND MALVA SYLVESTRIS FLOWER, CORRESPONDING TO 0.25 G OF LANCEOLATE LEAF AND 0.25 G OF SALIVA FLOWER, EXTRACTION SOLVENT: WATER
2.16.840.1.113883.3.6905.2
0‑L
300000004580
2,4(1H,3H)-Pyrimidinedione, 5-[6-methyl-5[(1S,2R)-2-(1-methylethyl)cyclopropyl]-3pyridazinyl]-5-{6-methyl-5-[(1S,2R)-2-(propan2-yl)cyclopropyl]pyridazin-3-yl}pyrimidine2,4(1H,3H)-dione
2.16.840.1.113883.3.6905.2
0‑L
300000018871
Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, Indiana serotype, encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax, HBZ, p12I and p30II
2.16.840.1.113883.3.6905.2
0‑L
300000037838
Liquid extract from fresh Purple coneflower herb corresponding to 222-406 mg of fresh purple solhatt, equivalent to 72 mg of dried purple solhatt. Extraction solvent: ethanol 57.3% M/M
2.16.840.1.113883.3.6905.2
0‑L
300000054211
4-Benzoyl-D-phenylalanyl-D-seryl-D-tryptophyl-D-seryl-2,3,4,5,6-pentafluoro-D-phenylalanyl-3-cyclohexyl-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D-arginine acetate
2.16.840.1.113883.3.6905.2
0‑L
300000033386
Dry extract of Horse-chestnut equivalent to 1.08 - 1.60 g of Horse-chestnut corresponding to 50 mg of triterpene glycosides calculated as aescin, extraction solvent: ethanol 50% (v/v)
2.16.840.1.113883.3.6905.2
0‑L
300000041897
L-Asparaginyl-L-tyrosinyl-L-seryl-L-glutaminyl-L-isoleucyl-L-tyrosinyl-L-prolyl-L-prolyl-L-asparaginyl-L-valyl-L-asparaginyl-L-lysyl-L-isoleucyl-L-arginyl-L-glutamyl-L-alanine acetate
2.16.840.1.113883.3.6905.2
0‑L
300000051796
Potassium sodium 4-[[2-(3-carboxylatopropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate
2.16.840.1.113883.3.6905.2
0‑L
100000183760
STANDARDIZED DRY EXTRACT OF AESCULUS HIPPOCASTANUM SEED (5-8:1) CORRESPONDING TO 40-50MG OF TRITERPENE GLYCOSIDES, EXPRESSED AS PROTOAESCIGENIN, EXTRACTION SOLVENT: ETHANOL 80% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000041173
Methyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2'-methoxy-2',13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5'-1,3-dioxolane]-4'-ylidene]acetate
2.16.840.1.113883.3.6905.2
0‑L
300000049593
5-Fluoro-2-[(4-{7-[(1S,3S,4R)-5-methylidene-2-azabicyclo[2.2.2]octane-3-carbonyl]-2,7-diazaspiro[3.5]nonan-2-yl}pyrimidin-5-yl)oxy]-N,N-di(propan-2-yl)benzamide mono-(2R,3R)-tartrate
2.16.840.1.113883.3.6905.2
0‑L
100000159859
EXTRACT (1:11) OF GENTIAN ROOT CUT, VERBENA HERB CUT, COMMON SORREL HERB CUT, ELDER FLOWER RUBBED, PRIMULA FLOWER WITH CALYX CUT: (1:3:3:3:3), EXTRACTION SOLVENT: ETHANOL, 59% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000004100
Adeno-associated viral vector serotype 8 containing the 5'-fragment of CEP290 gene coding sequence fused to the 5'-coding sequence of the mutated DnaE intein from Nostoc punctiforme
2.16.840.1.113883.3.6905.2
0‑L
300000051642
7-[4-Methyl-6-(2-methylpropyl)pyridin-3-yl]-6-oxo-N-[(1R,2S)-2-(prop-2-enoylamino)cyclopentyl]-2-thia-5,7,11-triazatricyclo[6.3.1.04,12]dodeca-1(11),3,8(12),9-tetraene-3-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
100000170040
DISTILLATE FROM BITTER FENNEL FRUIT, BITTER ORANGE PEEL, GENTIAN ROOT, PEPPERMINT LEAVES, BLESSED THISTLE HERB (1,5 : 1,5 : 1,2 : 1,0 : 1,0), DISTILLATION AGENT: ETHANOL 27 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000046509
(S)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)-2-cyclopropyl-1-((4-fluorophenyl)sulfonyl)-2',3',5',6'-tetrahydrospiro[indoline-3,4'-thiopyran]-5-carboxamide 1',1'-dioxide
2.16.840.1.113883.3.6905.2
0‑L
300000051110
(2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one
2.16.840.1.113883.3.6905.2
0‑L
300000052382
(3R,6S,9R,12R,15S)-6-cyclopropyl-3,8,9,15-tetramethyl-12-(2-methylpropyl)-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione sesquiphosphate monohydrate
2.16.840.1.113883.3.6905.2
0‑L
300000052905
[(6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-(fluoromethylsulfanylcarbonyl)-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate
2.16.840.1.113883.3.6905.2
0‑L
100000130325
DRY EXTRACT FROM MILK THISTLE (36-44:1) CORRESPONDING TO 108 MG OF SILYMARIN (HPLC) OR 140 MG SILYMARIN (DNPH), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE 98% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000037401
Standardised dry extract from Cascara sagrada (DER 4-6:1), equivalent to 15 mg of hydroxyanthracene heterosides, expressed as cascarosides a, Extraction solvent: ethanol 60% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000044704
DNA plasmid encoding the human IgG3 monoclonal antibody hinge and CH3, influenza A/Shanghai/2/2017 (H7N9) hemagglutinin and a single-chain variable fragment specific against HLAII
2.16.840.1.113883.3.6905.2
0‑L
300000049402
Turkey herpesvirus, strain rHVT/ND/H9 (cell-associated), expressing fusion protein gene of Newcastle disease virus and hemagglutinin gene of Avian influenza virus subtype H9, Live
2.16.840.1.113883.3.6905.2
0‑L
300000050332
Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5, Live
2.16.840.1.113883.3.6905.2
0‑L
300000056621
({1'-[(11S)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-4',6'-dioxo-1',2',4',6'-tetrahydrospiro[cyclopropane-1,3'-pyrido[1,2-b]pyridazin]-5'-yl}oxy)methyl methyl carbonate
2.16.840.1.113883.3.6905.2
0‑L
100000175271
(8S,11R,13S,14S,17S)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(3-(4-methylsulfonylphenyl)prop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one
2.16.840.1.113883.3.6905.2
0‑L
100000182889
Recombinant Vesicular Stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the Zaire ebolavirus (strain Kikwit-1995) surface glycoprotein
2.16.840.1.113883.3.6905.2
0‑L
100000183263
Allogeneic pancreatic cancer cells derived from panc 10.05 tumor cell line transfected with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor gene
2.16.840.1.113883.3.6905.2
0‑L
300000028153
Dry extract from Ginkgo (35-67:1), refined and quantified corresponding to 22 - 27% flavonoids, 2.6 - 3.2% bilobalide, 2.8 - 3.4% ginkgolides, Extraction solvents: acetone, water
2.16.840.1.113883.3.6905.2
0‑L
300000041674
Fusion protein containing a humanised Llama single domain antibody against PSMA, a humanised Llama single domain antibody against HAS and a humanised single chain Fv against CD3e
2.16.840.1.113883.3.6905.2
0‑L
100000183262
Allogeneic pancreatic cancer cells derived from panc 6.03 tumor cell line transfected with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor gene
2.16.840.1.113883.3.6905.2
0‑L
300000032853
Liquid extract (1:5) from Melissa leaf, Hawthorn leaf and flower, Matricaria flower, Angelica archangelica root, Caraway fruit (8:7:2:2:1), extraction solvent: ethanol 40% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000033281
2-amino-4-[(4aS)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1H,12H-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-benzo[b]thiophene-3-carbonitrile
2.16.840.1.113883.3.6905.2
0‑L
300000041049
Autologous CD34+ enriched population containing haematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding the human programmed death-ligand 1
2.16.840.1.113883.3.6905.2
0‑L
300000054707
Turkey herpesvirus, strain rHVT/ND/IBD (cell-associated), expressing fusion protein gene of Newcastle disease virus and VP2 protein gene of Infectious bursal disease virus, Live
2.16.840.1.113883.3.6905.2
0‑L
100000159896
EXTRACT (1:38.5) FROM GENTIAN ROOT, VERBENA HERB, COMMON SORREL HERB, ELDER FLOWER, PRIMULA FLOWER WITH CALYX (1:3:3:3:3), EXTRACTING AGENTS: ETHANOL 59 % (V/V), PURIFIED WATER
2.16.840.1.113883.3.6905.2
0‑L
300000017101
3-amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000043839
Turkey herpesvirus, strain HVT-IBD-ND (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus and fusion protein gene of Newcastle disease virus, Live
2.16.840.1.113883.3.6905.2
0‑L
300000050574
4-(5-(2-((1R,5S,7aS)-1-(3,5-Bis(trifluoromethyl)phenyl)tetrahydro-3-oxo-1H,3H-pyrrolo(1,2-C)oxazol-5-yl)-4-(trifluoromethyl)phenyl)-6-methoxy-3-pyridinyl)-3-methyl-benzoic acid
2.16.840.1.113883.3.6905.2
0‑L
100000174893
DRY EXTRACT OF PINUS SYLVESTRIS POLLEN, ZEA MAYS POLLEN, SECALE CEREALE POLLEN, DACTYLIS GLOMERATA POLLEN AND ZEA MAYS PISTIL (DER 3-4:1), EXTRACTION SOLVENT: ACETONE 5% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
100000178070
REFINED AND STANDARDIZED DRY EXTRACT OF MILK THISTLE FRUIT (24-27: 1) CORRESPONDING TO 77.76 - 95.04 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ACETONE 95 %
2.16.840.1.113883.3.6905.2
0‑L
300000016580
Mycobacterium bovis, strain Bacillus Calmette-Guérin, subtype Prague, containing listeriolysin encoding gene from Listeria monocytogenes in the place of urease C encoding gene
2.16.840.1.113883.3.6905.2
0‑L
300000033908
Refined and quantified dry extract from ginkgo leaf (35-45: 1), corresponding to 15 mg of flavone glycosides and 3.5 mg of terpenlactone, Extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000044639
N-[(3R,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-2-aminoacetamide monohydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000046755
L-Asparaginyl-L-tyrosinyl-L-seryl-L-glutaminyl-L-isoleucyl-L-tyrosinyl-L-prolyl-L-prolyl-L-asparaginyl-L-valyl-L-asparaginyl-L-lysyl-L-isoleucyl-L-arginyl-L-glutamyl-L-alanine
2.16.840.1.113883.3.6905.2
0‑L
300000050872
Methyl-(1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate-mono(4-methylbenzenesulfonate) monohydrate
2.16.840.1.113883.3.6905.2
0‑L
300000054918
16,17-Dimethoxy-21-[2-(methylamino)ethyl]-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-one-2,2,2-trifluoroacetic acid
2.16.840.1.113883.3.6905.2
0‑L
300000056620
2-Fluoro-N-{(83R,84R)-83-hydroxy-58-(propan-2-yl)-4,6-diaza-1(1)-isoquinolina-5(4,2)-pyrazolo[1,5-a][1,3,5]triazina-8(4)-piperidina-2(1,2)-benzenaoctaphan-16-yl}prop-2-enamide
2.16.840.1.113883.3.6905.2
0‑L
100000141671
OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE
2.16.840.1.113883.3.6905.2
0‑L
300000003961
7-(4-((4-((5s)-5-(acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid sodium
2.16.840.1.113883.3.6905.2
0‑L
300000039847
7-acetoxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl 2,2-dimethyl-1,3-dioxolane-4-carboxylate
2.16.840.1.113883.3.6905.2
0‑L
300000043699
Methyl(R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-3-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
2.16.840.1.113883.3.6905.2
0‑L
300000044848
Methyl(R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-2-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
2.16.840.1.113883.3.6905.2
0‑L
100000090160
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000090163
HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000090164
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163404
HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163405
HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163406
HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163407
HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163408
HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000178075
LIQUID EXTRACT FROM A MIXTURE OF SOLANUM DULCAMARA STEM, MARRUBIUM VULGARE LEAF, ANISEED, WILD THYME AND THYME (1:2.33:3.33:2.33:19) (DER: 1: 6-7), EXTRACTION SOLVENT: WATER
2.16.840.1.113883.3.6905.2
0‑L
300000042419
(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methylsulfanyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
2.16.840.1.113883.3.6905.2
0‑L
300000054871
Natural killer cell engager composed of a single-chain variable fragment against hepatocyte growth factor receptor, a Fab arm against NKG2D, and an Fc fragment against CD16a
2.16.840.1.113883.3.6905.2
0‑L
100000090165
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000130744
DRY EXTRACT FROM MILK THISTLE FRUIT (DER 36-44:1) EQUIVALENT TO 75.0-80.9% SILYMARIN (DNPH) AND 58.0-62.5% (HPLC), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE
2.16.840.1.113883.3.6905.2
0‑L
100000169936
Turkey herpesvirus, strain HVP360 (cell-associated), expressing fusion protein gene of Newcastle disease virus and VP2 protein gene of Infectious bursal disease virus, Live
2.16.840.1.113883.3.6905.2
0‑L
300000023939
4-(4-(3-((2-(tert-butylamino)ethyl)amino)-6-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)pyridin-2-yl)piperidin-1-yl)-5,5-dimethyl-5,7-dihydro-6H-pyrrolo(2,3-d)pyrimidin-6-one
2.16.840.1.113883.3.6905.2
0‑L
300000032852
Liquid extract (1:5) from St. John's wort, chamomile flower, peppermint leaf, rhubarb root, rose fruit, fennel fruit, coriander fruit, extraction solvent: ethanol 70% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
100000168580
DISTILLATE (1:7) FROM EUCALYPTUS LEAVES, PEPPERMINT LEAVES, ANISE FRUITS, BITTER FENNEL FRUITS, SAGE LEAVES (2 : 2 : 1.5 : 1.5 : 1): DISTILLATION AGENT: ETHANOL 36 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000004120
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of DnaB intein from Rhodothermus marinus fused to the 3'-fragment of CEP290 gene coding sequence
2.16.840.1.113883.3.6905.2
0‑L
300000041398
(2's,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro(indole-3,3'-pyrrolidine)-5'-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000041532
N-(2-fluoro-6-methylphenyl)-5,6-dihydro-6-(4-(((5-methyl-2-(7-oxa-2-azaspiro(3.5)non-2-yl)-3-pyridinyl)carbonyl)amino)benzoyl)-4H-thieno(3,2-d)(1)benzazepine-2-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000049514
3-[(3R)-3-[1-[5-Chloro-4-[[(1R)-1-(2,4-dichlorophenyl)ethyl]amino]-6-methylpyrimidin-2-yl]azetidin-3-yl]piperidin-1-yl]-1-methylcyclobutane-1-carboxylic acid hemi-tartrate
2.16.840.1.113883.3.6905.2
0‑L
300000052837
[(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]boronic acid
2.16.840.1.113883.3.6905.2
0‑L
100000143266
EXTRACTUM SPISSUM COMPOSITUM EX: HARPAGOPHYTI RADICE (4 PARTS), ECHINACEAE PURPUREAE HERBA (3 PARTS), ULMARIAE FLORE (3 PARTS) DER 2-4:1, EXTRACTING AGENT: ETHANOL, WATER
2.16.840.1.113883.3.6905.2
0‑L
100000175593
3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-2,4,6,8(13)-tetraen-3-yl]-4-{imidazo[1,2-a]pyridin-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione
2.16.840.1.113883.3.6905.2
0‑L
300000009360
Liquid extract from gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3) (DER 1:5.9), extraction solvent: ethanol 59% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000027009
Liquid extract from gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3) (DER 1:5.6), Extraction solvent: ethanol 59% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000041327
(s)-N-(4-hydroxyphenyl)-3-(6-(3-(morpholinomethyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)benzo[d][1,3]dioxol-5-yl)-N-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000041509
(5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000042211
Dry extract of horse chestnut, standardised (DER 5-7:1), adjusted to 12.5 mg of triterpene glycosides calculated as protoaescigenin, Extraction solvent: ethanol 50% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000042544
2-[(1S)-1-[(2S,5R)-5-[4-Chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1-yl)-2H-pyrido[1,2-a]pyrazine-1,6-dione
2.16.840.1.113883.3.6905.2
0‑L
300000047316
Modified Vaccinia Ankara-Bavarian Nordic encoding carcinoembryonic antigen, mucin-1 , CD80, intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3
2.16.840.1.113883.3.6905.2
0‑L
300000049793
(4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-Hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
100000180998
Human T lymphoid progenitor cells obtained after a brief period of ex vivo culture in the presence of the fusion protein DL-4, retronectin and a combination of cytokines
2.16.840.1.113883.3.6905.2
0‑L
300000013149
Sodium 3-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one
2.16.840.1.113883.3.6905.2
0‑L
300000020671
Human Papillomavirus type 16 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide, hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived
2.16.840.1.113883.3.6905.2
0‑L
300000020672
Human Papillomavirus type 18 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide, hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived
2.16.840.1.113883.3.6905.2
0‑L
300000040378
L-alanyl-L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-a-glutamyl-L-leucine
2.16.840.1.113883.3.6905.2
0‑L
300000040989
1-Hydroxy-2-methylpropan-2-aminium (S)-3-(6-(difluoromethoxy)13midazol-3-yl)-3-oxo-2-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)13midazolidine-1-yl)propanoate
2.16.840.1.113883.3.6905.2
0‑L
300000041483
(1S)-1-(4-chlorophenyl)-1,4-dihydro-6-methoxy-7-(1-methylethoxy)-2-(4-(methyl((trans-4-(4-methyl-3-oxo-1-piperazinyl)cyclohexyl)methyl)amino)phenyl)-3(2H)-isoquinolinone
2.16.840.1.113883.3.6905.2
0‑L
300000042589
(4S,4aS,5aR,12aS)-4-(diethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-8-[(2S)-pyrrolidin-2-yl]-7-(trifluoromethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000051923
(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-Hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
100000170904
DRY EXTRACT OF HORSE CHESTNUT, STANDARDISED (DER 5-7:1), ADJUSTED TO 30 MG OF TRITERPENE GLYCOSIDES CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: ETHANOL 50 % (M/M)
2.16.840.1.113883.3.6905.2
0‑L
100000179994
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-CYSTEINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
300000017300
Soft extract from purple coneflower, corresponding to 300-600 mg purple coneflower herb and to 17-29 mg purple coneflower root, extraction solvent: ethanol 57.3 % (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000020691
Mixture of allergen extracts from Alnus spp., Fraxinus spp., Fagus spp., Betula spp., Ulmus spp., Corylus spp., Quercus spp., Planatus spp., Populus spp. and Salix spp.
2.16.840.1.113883.3.6905.2
0‑L
300000040250
Clostridium botulinum A, strain PM-12759 Hall-A, botulin A conjugated to protein NTNH, hemagglutinin HA17, hemagglutinin HA34, hemagglutinin HA23 and hemagglutinin HA48
2.16.840.1.113883.3.6905.2
0‑L
100000173488
EXTRACT (0,218:1) OF BITTER ORANGE PEEL, CONDURANGO, CLOVE, GINGER, CINNAMON AND ANGELICA ARCHANGELICA ROOT (625:10:9:5:2,5:1), EXTRACTION SOLVENT: ETHANOL 70% (V / V)
2.16.840.1.113883.3.6905.2
0‑L
100000174320
DRY EXTRACT (4.2-5.6:1) OF CASCARA 57-108 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE DERIVATIVES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 52% M/M
2.16.840.1.113883.3.6905.2
0‑L
100000179995
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ASPARTYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000179999
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-GLYCYL-L-ASPARTYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000183784
Adeno-associated viral vector serotype 8 containing the 5'-half region of CEP290 gene coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein
2.16.840.1.113883.3.6905.2
0‑L
300000037206
Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding to 22.5 mg silymarin, calculated as silibinin, Extraction solvent: methanol 98% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000039345
Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding to 70 mg of silymarin, calculated as silibinin, Extraction solvent: acetone 95% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000040809
7-(4-((4-((5S)-5-(acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000042365
5-[(4S)-4-hydroxy-4-methyl-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione
2.16.840.1.113883.3.6905.2
0‑L
300000046173
Ethyl(2E,4S)-4-({(2S)-2-[3-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-2-oxopyridin-1(2H)-yl]pent-4-ynoyl}amino)-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate monohydrate
2.16.840.1.113883.3.6905.2
0‑L
300000049196
Refined and standardized dry extract of Milk Thistle fruit (24-27:1), corresponding to 4.06 mg of silymarin expressed as silibinin. Extraction solvent: acetone 95% v/v
2.16.840.1.113883.3.6905.2
0‑L
300000054139
4-[[[4-[5-Chloro-2-[[trans-4-[[(1R)-2-methoxy-1-methyl-ethyl]amino]cyclohexyl]amino]-4-pyridinyl]-2-thiazolyl]amino]methyl]tetrahydro-2H-pyran-4-carbonitrile dimaleate
2.16.840.1.113883.3.6905.2
0‑L
300000057673
(14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid conjugated to bombesin and radiolabeled with technetium-99m
2.16.840.1.113883.3.6905.2
0‑L
300000057752
[(3S)-3-Amino-3-carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium butane-1,4-disulfonate butane-1,4-disulfonic acid
2.16.840.1.113883.3.6905.2
0‑L
100000139506
EXTRACTUM LIQUIDUM (1:3) EX: CHAMOMILLAE ANTHODIO, HYPERICI HERBA, GLYCYRRHIZAE RADICE, SALVIAE FOLIO, MENTHAE PIPERITAE FOLIO (2,5 P: 2,5 P.: 2,0 P.: 2,0 P.: 1,0 P.)
2.16.840.1.113883.3.6905.2
0‑L
100000174319
LIQUID EXTRACT (1:1.0-1.2) OF CASCARA 500 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE GLYCOSIDES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 30% M/M
2.16.840.1.113883.3.6905.2
0‑L
100000179996
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ARGINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000183279
Adeno-associated viral vector serotype 8 containing the 5'-half region of ABCA4 gene coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein
2.16.840.1.113883.3.6905.2
0‑L
300000016600
Mixture of allergen extracts of Phleum pratense, Dactylis glomerata, Poa pratensis, Holcus lanatus, Festuca elatior and Lolium perenne polymerized with glutaraldehyde
2.16.840.1.113883.3.6905.2
0‑L
300000032682
Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene
2.16.840.1.113883.3.6905.2
0‑L
300000033927
Autologous CD34+ cell enriched population containing haematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding the human ADA2 gene
2.16.840.1.113883.3.6905.2
0‑L
300000039365
(R)-1-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000052894
(8R,9S,13S,14S,17S)-13-Methyl-7-[9-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonylsulfinyl]nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
2.16.840.1.113883.3.6905.2
0‑L
100000172697
MILK THISTLE DRY EXTRACT, REFINED AND STANDARDISED 123,0 - 208,3 MG CORRESPONDING TO 83,3 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE
2.16.840.1.113883.3.6905.2
0‑L
100000179993
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ALANYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000184187
Autologous skin equivalent graft composed of keratinocytes and fibroblasts genetically corrected by CRISPR/Cas9-mediated excision of mutation-carrying COL7A1 exon 80
2.16.840.1.113883.3.6905.2
0‑L
300000026364
Standardised dry extract of frangula bark (DER 5-7: 1) corresponding to 15 mg of glucofrangulins expressed as glucofrangulin A, extraction solvent: ethanol 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000037257
Dry extract from Hippophae rhamnoides, refined and standardised (DER 35-50:1), corresponding to 110 mg silymarin, calculated as silibin, Extraction solvent: methanol
2.16.840.1.113883.3.6905.2
0‑L
300000041564
Refined and quantified dry extract of ginkgo leaf (35-67:1), quantified to 24% of ginkgo glycosides, 6% ginkgolides-bilobalide, Extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000046508
Refined and quantified dry extract from Ginkgo leaf, corresponding to 9.6 mg of glycosides and 2.4 mg ginkgolides and bilobalide, Extraction solvent: acetone 60% M/M
2.16.840.1.113883.3.6905.2
0‑L
300000056642
(10R)-7-Amino-12-fluoro-2-(2H3)methyl-10,16-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile
2.16.840.1.113883.3.6905.2
0‑L
300000057674
(14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid conjugated to bombesin and radiolabeled with lutetium-177
2.16.840.1.113883.3.6905.2
0‑L
100000179997
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-SERYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000179998
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-VALYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
300000011402
Dry extract from tribulus terrestris herba (35-45:1), corresponding to 125 mg furostanol saponins calculated as protodioscin, extraction solvent: methanol 80% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000044020
[(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-pyridin-2-ylhepta-2,4-dien-2-yl]-1-oxacyclododec-4-en-6-yl]4-methylpiperazine-1-carboxylate
2.16.840.1.113883.3.6905.2
0‑L
300000052893
(1S,3S,5S,6S,10R,12S,13S,15S,21S)-15-Fluoro-6-(2-hydroxyacetyl)-5,8,8,21-tetramethyl-2,7,9-trioxahexacyclo[11.8.0.01,3.05,12.06,10.016,21]henicosa-16,19-dien-18-one
2.16.840.1.113883.3.6905.2
0‑L
100000184144
MILK THISTLE FRUIT DRY EXTRACT, REFINED AND STANDARDISED (22-27:1) CORRESPONDING TO 200 MG OF SYLIMARIN, CALCULATED AS SYLIBIN, EXTRACTION SOLVENT: ACETONE 95% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000013240
Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding to 140 mg silymarin, calculated as silibinin, extraction solvent: acetone 95% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000018300
Pneumococcal polysaccharide serotype 23F conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000032854
Liquid extract (1:2) from Valerian root, Melissa herb, Angelica archangelica root, Hop strobile, Lavender flower (5:5:4:3:3), extraction solvent: ethanol 60% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000041471
4-((9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide
2.16.840.1.113883.3.6905.2
0‑L
300000050858
Methyl-(1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate-mono(4-methylbenzenesulfonate)
2.16.840.1.113883.3.6905.2
0‑L
300000051415
Autologous T-cells expressing an antibody coupled T-cell receptor composed of CD16 extracellular domain, CD3zeta-signaling domain and a 4-1BB co-stimulatory domain
2.16.840.1.113883.3.6905.2
0‑L
300000051582
Extract of Phoradendron leucarpum herb (1:50), Extraction solvent: sodium monohydrogen phosphate dihydrate, ascorbic acid and water for injection (2.03:0.34:97.63)
2.16.840.1.113883.3.6905.2
0‑L
300000052817
Cis-4-(2-fluoro-4-methoxy-5-{[(1S,2R,3S,4R)-3-{[(1-methylcyclobutyl)methyl]carbamoyl}bicyclo[2.2.1]heptan2-yl]carbamoyl}phenoxy)-1-methylcyclohexanecarboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000055990
Dry extract of Rhubarb (DER: 3-5 :1), corresponding to 12.5 mg of hydroxyanthracene glycosides, expressed as rhein-8-glucoside, Extraction solvent: ethanol 70% V/V
2.16.840.1.113883.3.6905.2
0‑L
100000175091
2,2-dimethylpropyl (2S)-2-[[[(2R,3R,4R,5R)-5-(2-amino-6-methoxypurin-9-yl)-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate
2.16.840.1.113883.3.6905.2
0‑L
300000013150
3-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one
2.16.840.1.113883.3.6905.2
0‑L
300000018294
Pneumococcal polysaccharide serotype 6B conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018295
Pneumococcal polysaccharide serotype 7F conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018296
Pneumococcal polysaccharide serotype 9V conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018297
Pneumococcal polysaccharide serotype 14 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000034979
Autologous haematopoietic stem and progenitor cell population containing CD34+ cells transduced with a lentiviral vector encoding the TCIRG1 cDNA ex vivo expanded
2.16.840.1.113883.3.6905.2
0‑L
300000038478
Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene
2.16.840.1.113883.3.6905.2
0‑L
300000043943
(2R,4E)-7-chloro-4-(2-oxo-1-phenyl-pyrrolidin-3-ylidene)-1,2,3,4-tetrahydroquinoline-2-carboxylic acid, (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentanol salt
2.16.840.1.113883.3.6905.2
0‑L
300000052886
[2-[(1S,2S,8S,10S,11S,14R,15S,17S)-14-Acetyloxy-8-fluoro-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-14-yl]-2-oxoethyl] acetate
2.16.840.1.113883.3.6905.2
0‑L
300000053091
(7S,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-one
2.16.840.1.113883.3.6905.2
0‑L
300000056634
6-(3-Hydroxy-3-methylazetidin-1-yl)-4-(6-{6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl}pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
2.16.840.1.113883.3.6905.2
0‑L
300000057747
Butan-2-yl [1-methyl-4-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]piperazin-1-ium-1-yl]methyl carbonate methanesulfonate
2.16.840.1.113883.3.6905.2
0‑L
100000143028
AQUEOUS EXTRACT FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER, 0,095 G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS
2.16.840.1.113883.3.6905.2
0‑L
300000003968
L-valyl-L-cysteinyl-L-histidyl-L-seryl-L-lysyl-L-threonyl-L-arginyl-L-seryl-L-asparaginyl-L-prolyl-L-glutamyl-L-asparaginyl-L-asparaginyl-L-valylglycyl-L-leucine
2.16.840.1.113883.3.6905.2
0‑L
300000011380
Dry extract from horse chestnut seed (4.5-5.5:1) corresponding to 50 mg triterpene glycosides calculated as anhydrous aescin, extraction solvent: ethanol 50% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000018291
Pneumococcal polysaccharide serotype 1 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018292
Pneumococcal polysaccharide serotype 4 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018293
Pneumococcal polysaccharide serotype 5 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000044122
(2S,3R,4S,5S,6R)-2-[4-[(3R,3aR,6S,6aR)-3-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2.16.840.1.113883.3.6905.2
0‑L
100000131733
HIPPOCASTANI SEMEN EXTRACTUM SICCUM (5,3 - 7,7 : 1), ADJUSTED TO 40 MG OF TRITERPENE GLYCOSIDES, CALCULATED AS ANHYDROUS ESCINE, EXTRACTION MEDIUM: METHANOL 80%
2.16.840.1.113883.3.6905.2
0‑L
100000177747
1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-(1,2,4)triazolo(4,3-b)pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone (Z)-but-2-enedioic acid
2.16.840.1.113883.3.6905.2
0‑L
100000182954
Adeno-associated viral vector serotype 8 containing a functional copy of the codon-optimised F8 cDNA encoding the B-domain deleted human coagulation factor VIII
2.16.840.1.113883.3.6905.2
0‑L
300000022311
(S,E)-N-(1-((5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)pent-4-yn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methylbut-2-enamide succinate
2.16.840.1.113883.3.6905.2
0‑L
300000024532
[14C]-1-{3,5-dimethyl-4-[2-({4-oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-8-yl}sulfonyl)ethyl]phenyl}-5,5-dimethylimidazolidine-2,4-dione
2.16.840.1.113883.3.6905.2
0‑L
300000040529
Mixture of heat-inactivated, non-lysate, bacterial concentrates of Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris and Enterococcus faecalis (1:1:1:1)
2.16.840.1.113883.3.6905.2
0‑L
300000041473
3-[(3R,3aR,5aS,6R,7z,9aS,9bS)-7-hydroxyimino-3a,6-dimethyl-3-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,5a,8,9,9a,9b-decahydrocyclopenta[a]naphthalen-6-yl]propan-1-ol
2.16.840.1.113883.3.6905.2
0‑L
300000043981
S-(4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl)-6a,9a-difluoro-17a-(furan-2-yl)carbonyloxy-11-beta-hydroxy-16a-methyl-3-oxoandrosta-1,4-diene-17-beta-carbothioate
2.16.840.1.113883.3.6905.2
0‑L
100000181823
DRY EXTRACT FROM FRESH HORSE CHESTNUT SEEDS CORRESPONDING TO 50 MG TRITERPENE GLYCOSIDES, CALCULATED AS ANHYDROUS B-AESCIN, EXTRACTION SOLVENT: ETHANOL 60% M/M
2.16.840.1.113883.3.6905.2
0‑L
300000011300
Dry extract from bearberry leaf corresponding to 62.3-77.7 mg of hydroquinone derivative calculated as anhydrous arbutin, extraction solvent: ethanol 60% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000019132
N-((1R,2S,5R)-5-((1,1-dimethylethyl)amino)-2-((3S)-3-((7-(1,1-dimethylethyl)pyrazolo(1,5-a)-1,3,5-triazin-4-yl)amino)-2-oxo-1-pyrrolidinyl)cyclohexyl)acetamide
2.16.840.1.113883.3.6905.2
0‑L
300000027031
N-(2,6-Diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000038472
Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with a lentiviral vector encoding for the N-acetylgalactosamine 6-sulfatase cDNA
2.16.840.1.113883.3.6905.2
0‑L
300000041446
(6S,9S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide
2.16.840.1.113883.3.6905.2
0‑L
300000043983
(3S)-3-[2-(6-Amino-2-fluoropyridin-3-yl)-4-fluoro-1H-imidazol-5-yl]-7-[5-chloro-2-(1Htetrazol-1-yl)phenyl]-2,3-dihydroindolizin-5(1H)-one 3-hydroxybenzoic acid
2.16.840.1.113883.3.6905.2
0‑L
300000047774
Leu-Asn-Ser-Lys-Ile-Ala-Phe-Lys-Ile-Val-Ser-Gln-Glu-Pro-Ala conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000047775
Thr-Pro-Met-Phe-Leu-Leu-Ser-Arg-Asn-Thr-Gly-Glu-Val-Arg-Thr conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000047798
Arg-Glu-Gly-Ile-Ala-Phe-Arg-Pro-Ala-Ser-Lys-Thr-Phe-Thr-Val conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000047799
Asn-Ile-Lys-Val-Lys-Asp-Val-Asn-Asp-Asn-Phe-Pro-Met-Phe-Arg conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000052153
Adeno-associated viral vector serotype 9 containing the human MECP2 gene, an intron encoding a miRNA generating sequence, and complementary miRNA binding sites
2.16.840.1.113883.3.6905.2
0‑L
300000056041
Milk thistle dry extract, refined and standardised (22-27:1) of nominal content of silymarin, expressed as silibinin 58%, Extraction solvent: 95% acetone (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000027279
Dry extract from senna pods and (DER 4.5-5.5:1), corresponding to 19.5 mg of hydroxyanthracene glycosides, expressed as sennoside B, Extraction solvent: water
2.16.840.1.113883.3.6905.2
0‑L
300000031916
3-(4-{(5S)-4-Amino-2-[6-chloro-1-(3,3,4,4,4-pentafluorobutyl)-1H-indazol-3-yl]-5-methyl-6-oxo6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-5-yl}phenyl)propanoic acid
2.16.840.1.113883.3.6905.2
0‑L
300000043587
Dry extract from milk thistle fruit, refined and standardised (DER 30:1), corresponding to 35 mg silymarin, calculated as silibin, Extraction solvent: acetone
2.16.840.1.113883.3.6905.2
0‑L
300000052854
[(1S,8R,9S,10S,13S,14S,17R)-17-Acetyl-6-chloro-1-(chloromethyl)-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
2.16.840.1.113883.3.6905.2
0‑L
300000054411
(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
2.16.840.1.113883.3.6905.2
0‑L
100000128887
HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5) FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
2.16.840.1.113883.3.6905.2
0‑L
100000143256
EXTRACTUM SPISSUM COMPOSITUM (4-7 : 1) EX: BETULAE FOLIO 4,40 CZ., PETROSELINI RADICE 2,66 CZ., PHASEOLI PERICARPIO 1,00 CZ., EKSTRAHENT: METANOL 90 % [V/V])
2.16.840.1.113883.3.6905.2
0‑L
100000177372
3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide mono methanesulfonic acid salt
2.16.840.1.113883.3.6905.2
0‑L
300000004140
Combination of three adeno-associated viral vectors of serotype 8 containing the 5'-, the body- and the 3'- coding sequences of human CEP290 fused to inteins
2.16.840.1.113883.3.6905.2
0‑L
300000020954
2-[1-(3-{6-[(1E)-(hydroxyimino)methyl]-5-methyl-4-oxo-7-propyl-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-2-yl}-4-propoxybenzenesulfonyl)piperidin-4-yl]ethyl nitrate
2.16.840.1.113883.3.6905.2
0‑L
300000025463
Dry extract from Cucurbita pepo seeds deffatted (DER 5-10:1), extraction solvents: sodium hydrogen carbonate, sodium chloride and purified water (3-6,1-90,9)
2.16.840.1.113883.3.6905.2
0‑L
300000027791
Dry extract from cranberry fruit juice, corresponding to 36 mg of proanthocyanidins, calculated as proanthocyanidin A2, Extraction solvent: ethanol 70% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000033589
(2E)-N,N-Dimethyl-4-{[2-({5-[(1Z)-4,4,4-trifluoro-1-(3-fluoro-1H-indazol-5-yl)-2-phenylbut-1-en-1-yl]pyridin-2-yl}oxy)ethyl]amino}but-2-enamide hydrochloride
2.16.840.1.113883.3.6905.2
0‑L
300000041501
2-((R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide
2.16.840.1.113883.3.6905.2
0‑L
300000043020
Dry extract of crude pollen of Secale cereale, Phleum pratense and Zea mays (30:1.5:1), Extraction solvent water:acetone:sodium laurilsulfate (27:1:0.01 w/w)
2.16.840.1.113883.3.6905.2
0‑L
300000044691
N-[(3R,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-2-aminoacetamide
2.16.840.1.113883.3.6905.2
0‑L
300000046674
Liquid extract from fresh purple coneflower root (DER 1:11), corresponding to 17-29 mg of fresh purple coneflower root, extraction solvent: ethanol 57.3% M/M
2.16.840.1.113883.3.6905.2
0‑L
300000051751
Salmonella typhi, strain Ty21a, Live encoding a fusion protein composed of prostate specific antigen, cholera toxin B subunit and a secretion signal sequence
2.16.840.1.113883.3.6905.2
0‑L
300000054366
Allergenic extract of grass pollen mixture: Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense and Poa pratensis (1:1:1:1:1), polymerised
2.16.840.1.113883.3.6905.2
0‑L
100000143027
DISTILLATE FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER, 0,095 G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS
2.16.840.1.113883.3.6905.2
0‑L
100000174280
DRY EXTRACT OF HORSE CHESTNUT SEEDS (5-8:1) ADJUSTED TO 50 MG OF TRITERPENE GLYCOSIDES CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: METHANOL 80 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000015541
Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of Cytomegalovirus, Adenovirus and Epstein-Barr virus
2.16.840.1.113883.3.6905.2
0‑L
300000032960
1-((3S,8S,9S,10R,13S,14S,17S)3-benzyloxy-10,13,17-trimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthrene-17-yl)ethan-1-one
2.16.840.1.113883.3.6905.2
0‑L
300000037318
Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding to 110 mg silymarin, calculated as silibinin, Extraction solvent: methanol
2.16.840.1.113883.3.6905.2
0‑L
300000042171
Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala-His-Tyr-Asn-Ile-Val-Thr-Phe-Cys-Cys-Lys-Cys-Asp-Ser-Thr-Leu-Arg-Leu-Cys-Val-Gln-Ser-Thr-His-Val-Asp-Ile-Arg trifluoroacetate
2.16.840.1.113883.3.6905.2
0‑L
300000044062
Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp-Ser-Ser-Glu-Glu-Glu-Asp-Glu-Ile-Asp-Gly-Pro-Ala-Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala-His-Tyr-Asn-Ile-Val-Thr trifluoroacetate
2.16.840.1.113883.3.6905.2
0‑L
300000044063
Met-His-Gly-Asp-Thr-Pro-Thr-Leu-His-Glu-Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr-Asp-Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp-Ser-Ser-Glu-Glu-Glu trifluoroacetate
2.16.840.1.113883.3.6905.2
0‑L
300000044064
Thr-Leu-Arg-Leu-Cys-Val-Gln-Ser-Thr-His-Val-Asp-Ile-Arg-Thr-Leu-Glu-Asp-Leu-Leu-Met-Gly-Thr-Leu-Gly-Ile-Val-Cys-Pro-Ile-Cys-Ser-Gln-Lys-Pro trifluoroacetate
2.16.840.1.113883.3.6905.2
0‑L
300000046063
(3E,3aR,5S,8bS)-5-hydroxy-8,8-dimethyl-3-({[(2R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yl]oxy}methylene)-3,3a,4,5,6,7,8,8b-octahydro-2H-indeno[1,2-b]furan-2-one
2.16.840.1.113883.3.6905.2
0‑L
300000047862
4-((4-((3,5-Bis(trifluoromethyl)benzyl)(5-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)-2,6-diethylpiperidine-1-carbonyl)oxy)cyclohexane-1-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000056616
52,92,96-Trichloro-85-cyclopropyl-6-oxa-2(2,5)-[1,3]benzoxazola-8(4,3)-[1,2]oxazola-5(1,4),9(1)-dibenzena-1(1)-cyclopropananonaphan-3-yne-27-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000056697
6-[[16-[(6-Carboxypyridin-2-yl)methyl]-1,4,10,13-tetraoxa-7,16-diazacyclooctadec-7-yl]methyl]-4-[2-(4-isothiocyanatophenyl)ethoxy]pyridine-2-carboxylic acid
2.16.840.1.113883.3.6905.2
0‑L
300000056855
Dry extract of Senna pods (5.6-6.8:1), adjusted to 12.5 mg of hydroxyanthracene glycosides, expressed as sennoside B, Extraction solvent: methanol 80% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
100000172436
MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF PHLEUM PRATENSE, FESTUCA ELATIOR, DACTYLIS GLOMERATA, LOLIUM PERENNE, POA PRATENSIS, SECALE CEREALE
2.16.840.1.113883.3.6905.2
0‑L
300000009248
Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phospatidylinositol and cholesterol
2.16.840.1.113883.3.6905.2
0‑L
300000024774
Modified growth hormone releasing-hormone fused to the light chain endopeptidase and the N-terminal domain of the heavy chain of botulinum toxin serotype D
2.16.840.1.113883.3.6905.2
This value set has 63646 codes in it. In order to keep the publication size manageable, only a selection (500 codes) of the whole set of codes is shown.

Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.
download XML JSON CSV SQL SVS FHIR (4.0) [xml / json